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ABSTRACT 
PALLADIUM-CATALYZED CROSS-COUPLING FOR THE SYNTHESIS OF THIENOISOQUINOLINES 
Nicholas Wong 
 
Thienoisoquinolines are biologically active heterocyclic systems that have potential as a breast cancer 
therapeutic.1  Optimizations and syntheses of functionalized thienoisoquinolines from commercially 
available starting material are described.  The syntheses address common limitations associated with 
classical palladium cross-coupling reactions such as the use of sensitive organometallic reagents and the 
production of high molecular weight metallic waste. 
 
The key intermediate (2) was synthesized in 2 steps from a commercially available starting material and 
used in two synthetic pathways to access different thienoisoquinoline isomers.  Undergoing a palladium 
catalyzed double C-H activation reaction allows access to the 3,4-thienoisoquinoline isomer (4).  The 
                                                          
1
 Coghlan, R. D.; Fobare, W. F.; Trybulski, E. J., Wyeth (2006) Thienoisoquinoline-Phenylsulfonamides and their use 
as ER-NFkappaB Inhibitors, US 2006/0154875 
iv 
 
ester functionality at C2 serves a dual purpose and was used both as a directing group and as a synthetic 
handle for further functionalization. 
The key intermediate (2) can also undergo a saponification reaction first to form the carboxylic acid (5).  
This allows for a palladium catalyzed decarboxylative cross-coupling, generating 2,3-thienoisoquinoline 
systems (6).  This can be further functionalized at the C5 position through a C-H activation or 
bromination reaction.  Furthermore, these functionalized 2,3-thienoisoquinoline systems can be 
synthesized through a one-pot decarboxylative cross-coupling & C-H activation sequence reducing the 
step count and improving efficiency.  In summary, an efficient synthesis of various functionalized 
thienoisoquinoline systems is described.  Both isomers of these biologically important compounds can 
be obtained from a common key intermediate allowing for an efficient and modular synthesis. 
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CHAPTER 1 – INTRODUCTION 
Chapter 1.1 – Green Chemistry 
Mankind has always sought the advancement of technology to further increase their quality of life.  
However, this advancement of technology has consumed a large portion of the planet’s natural 
resources.  Recently, with an emerging understanding of the human footprint on the planet, the 
implementation of procedures to minimize waste has become increasingly important.  Similarly, an 
increasing amount of attention has been placed on research and the pharmaceutical industry.  These 
concerns and environmental consciousness has since developed into the principles of green chemistry. 
The principles of green chemistry involve development of new chemistry and processes to minimize or 
completely eliminate by-product formation helping to reduce environmental impact.2  Emphasizing 
renewable starting materials, less dependence on fossil fuels and non-renewable chemical feedstock can 
lead to a self-sustained carbon neutral process.  To guide future research and development, 12 
principles of green chemistry were devised by Anastas and co-workers from the environmental 
protection agency in 1998 and are listed below.3 
1) Prevention 
2) Atom Economy 
3) Less Hazardous Chemical Syntheses 
4) Design Safer Chemicals 
5) Safer Solvents and Auxiliaries 
6) Design for Energy Efficiency 
7) Use of Renewable Feedstocks 
                                                          
2
 Green chemistry website http://www.greenchemistry.ca/ Accessed June 19, 2012. 
3
 Anastas, P. T.; Warner, J. C. Green Chemistry: Theory and Practice, Oxford University Press: New York, 1998, 30. 
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8) Reduce Derivatives 
9) Catalysis 
10) Designed for Degradation 
11) Real Time Analysis for Pollution Prevention 
12) Inherently Safer Chemistry for Accident Prevention 
These principles can be summarized into a single statement; “green chemistry uses reagents from 
preferably a renewable source producing minimal amounts of waste and toxic by-products towards the 
production of chemical products which have minimal toxicity for the environment.”2 
Although these twelve principles appear to be simple to implement, practical applications only allow for 
the employment of a fraction of these strategies for any one process.  These principles were developed 
to improve upon chemistry which was initially discovered and optimized in the early 20th century when 
the toxicity of many solvents and reagents were not well known and environmental consciousness was 
of little concern. 
The industrial process for the production of phloroglucinol was an example of an inefficient and 
environmentally detrimental process.4  This method of transforming 2,4,6-trinitrotoluene (8) through a 
series of oxidations and reductions was used up until the mid 1980s. 
 
Scheme 1 – Industrial process for the production of phloroglucinol 
 
                                                          
4
 Sheldon, R. A. Chem. Soc. Rev. 2012, 41, 1437. 
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From a classical point of view, this process to produce phloroglucinol is efficient, generating the desired 
product in an overall yield of >90%.  However, when considering all reagents used in the synthesis, this 
process also produces 40 kg of waste per kilogram of product formed which translates to only 5% of the 
overall mass of products formed.  From an atom economy perspective, the great majority of the mass 
formed is by-product containing metallic wastes.  These waste products were found to be too costly to 
properly dispose and this process was subsequently retired.4 
Large portions of waste produced in the synthesis of phloroglucinol (Scheme 1) are inorganic salts 
associated with the oxidizing and reducing agents.  These commonly used reactions employ the use of 
metal based redox reagents used in stoichiometric or higher equivalents producing an equal amount of 
high molecular weight inorganic salts as by-product.  As such, modern methods need to be established 
to replace these important reactions in efforts to minimize the impact on the environment. 
Catalysis has more recently been a major focus of research in efforts to develop new and more efficient 
reactions.  To minimize waste production in efforts to make reactions and processes greener, reactions 
employing catalytic rather than stoichiometric equivalents have recently been developed.  As an 
example, the hydrogenation of benzaldehyde (12) using a metal catalyst is a highly atom economical 
process (Scheme 2).  All atoms of the reagents are incorporated into the final product and there are no 
functional groups being eliminated as a by-product.  The use of a metal catalyst also allows for isolation 
and the possibility of recycling rather than disposed as waste. 
 
Scheme 2 – Catalytic hydrogenation as an atom economical process 
Recent advances in catalysis have been focused on the development of carbon-carbon bond forming 
reactions.  
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Chapter 1.2 - Palladium Cross-Coupling 
Carbon-carbon bonds have always had an important impact on the field of synthetic organic chemistry 
in the development of new methods, natural product synthesis and medicinal chemistry.  More recently, 
transition metal catalyzed carbon-carbon bond forming reactions have been established as an 
alternative to classical methods to generate these bonds.  To demonstrate the importance of these 
reactions in the development of therapeutics, a study of the reactions used by GlaxoSmithKline 
pharmaceuticals, AstraZeneca and Pfizer in the synthesis of 128 drug candidates was performed by 
Carey and co-workers in 2006.5 
 
Figure 1 – Breakdown of C-C bond forming reactions 
When categorizing all of the reactions performed, 11% of the reactions were carbon-carbon bond 
forming.  Further analysis of this set of reactions revealed that 22% of those carbon-carbon bond 
forming reactions were palladium catalyzed (Figure 1). 
To further emphasize the importance of palladium catalyzed carbon-carbon bond forming reactions, a 
second study was performed by Cooper and co-workers at GlaxoSmithKline.  This study surveyed 
reactions used towards the synthesis of clinical candidates for respiratory diseases.6 
                                                          
5
 Carey, J. S.; Laffan, D.; Thomson, C.; Williams, M. T. Org. Biomol. Chem. 2006, 4, 2337. 
6
 Cooper, T. W. J.; Campbell, I. B.; Macdonald, S. J. F. Angew. Chem. Int. Ed. 2010, 49, 8082. 
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Figure 2 – Survey of reactions used at GlaxoSmithKline towards respiratory disease clinical candidates 
Cooper also found that 22% of the reactions performed were palladium-catalyzed, which demonstrated 
the importance of these transformations (Figure 2).  The two studies performed encompassed the 
synthesis of different therapeutics for different disease areas, further demonstrating the versatility and 
applicability of palladium-catalysis in drug discovery. 
This class of reactions can be classified into two groups; classical methods and modern methods.  
Classical methods are composed of transformations such as the Suzuki, Hiyama, Negishi, Stille and 
Kumada reactions that employed the use of an organometallic species coupling with an aryl halide.  
These reactions facilitated and improved the synthesis of the aryl aryl bond (Scheme 3).7  These cross-
coupling reactions are chemioselective with aryl halides or oxygen-based leaving groups, commonly 
known as pseudo halides, and the corresponding organometallic group.  These reactions also are 
typically tolerant of other functional groups, thus allowing for broad applicability with a variety of 
substrates. 
                                                          
7
 For a review on palladium catalysis see: Hassan, J.; Sévignon, M.; Gozzi, C.; Schulz, E.; Lemaire, M. Chem. Rev. 
2002, 102, 1359. 
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Scheme 3 – Traditional Cross-Coupling Reactions 
These reactions employ the use of organosilianes (Hiyama), organozincs (Negishi), Grignard reagents 
(Kumada), organotins (Stille), and arylboronic acids/esters (Suzuki).  These organometallic cross-coupling 
partners typically employ high molecular weight metals and are typically functionalized resulting in the 
production of a stoichiometric amount of the corresponding metal salt as waste. 
In 2005, Li and co-workers presented an “efficient” Stille cross-coupling reaction for the formation of bi-
aryls (Scheme 4).8 
 
Scheme 4 – An “efficient” Stille cross-coupling reaction 
This reaction, through a classical evaluation is excellent since very low palladium catalyst loadings are 
required to generate the product in excellent yields.  However, when evaluating this reaction with the 
twelve principles of green chemistry, it employs a low catalyst loading which in turn produces minimal 
metallic waste.  However, the reaction also employs a higher than stoichiometric amount of phenyl-
                                                          
8
 Li, J.-H.; Liang, Y.; Wang, D.-P.; Liu, W.-J.; Xie, Y.-X.; Yin, D.-L. J. Org. Chem. 2005, 70, 2832. 
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tributyltin (15) in the reaction, generating 10% wasted reagent.  KF was added as an additive to the 
reaction in 3 equivalents and none of the mass associated with this reagent is incorporated into the final 
product.  Finally, comparing the molecular weight of the product and the stoichiometric metallic by-
product, approximately 2 g of inorganic salts are produced for every 1 g of desired product.  Similarly, 
other reactions employing organometallic reactions (Scheme 3) also produce stoichiometric amounts of 
high molecular weight inorganic salts as by-products.  
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Chapter 1.3 - Suzuki Reaction 
The Suzuki reaction has gained more attention than any other classical cross-coupling reaction and along 
with the Heck and Negishi reactions was awarded the Nobel Prize in chemistry in 2010.9,10  The reason 
for the success of the Suzuki reaction is in part due to the thermal stability of boronic acids/esters and11 
their inertness to water and oxygen allowing these reagents to be synthesized and stored long term 
without special precautions.  Furthermore, functionalized boronic acids and esters have been made 
commercially available, increasing their access to researchers.  These boronic acids have been applied to 
a wide range of cross-couplings, between two alkenes,12 an aryl group and an alkene,13 and more 
recently alkyl-alkyl couplings.14  Despite the wide range of reactivity, the Suzuki reaction is primarily 
known for the coupling of two aryl groups.15 
 
Scheme 5 – A general Suzuki reaction 
A general Suzuki reaction employs the use of organoboronic acids or boronic esters (17) and is reacted 
with an aryl halide (18) under palladium (0) catalysis conditions to yield bi-aryls (19) and a boron based 
salt (20).  Comparing the atom economy of the Suzuki reaction (Scheme 5) to the atom economy of the 
Stille reaction (Scheme 4), the Suzuki reaction can be considered a greener process based on the twelve 
principles of green chemistry.  The boron salts (20) that are formed as by-products of the Suzuki reaction 
are of much lower molecular weight than the tin salts formed in the Stille reaction.  The palladium in 
                                                          
9
 Nobelprize.org http://www.nobelprize.org/nobel_prizes/chemistry/laureates/2010/ accessed June 19, 2012. 
10
 For an excellent review see: Seechurn, C. C. C. J.; Kitching, M. O.; Colacot, T. J.; Snieckus, V. Angew. Chem. Int. Ed. 
2012, 51, 5062. 
11
 Miyaura, N.; Suzuki, A.; Chem. Rev. 1995, 95, 2457. 
12
 Honeycutt, J. B.; Riddle, J. M. J. Am. Chem. Soc. 1959, 81, 2593. 
13
 Larock, R. C.; Riefling, B. J. Org. Chem. 1978, 43, 1468. 
14
 a) Nicolaou, K. C.; Aversa, R. J.; Jin, J.; Rivas, F. J. Am. Chem. Soc. 2010, 132, 6855. b) Wilsily, A.; Tramutola, F.; 
Owston, N. A.; Fu, G. C. J. Am. Chem. Soc. 2012, 134, 5794. 
15
 Moriya, T.; Miyaura, N.; Suzuki, A. Synlett 1994, 149. 
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both cases is regenerated as the active Pd (0) species after each reaction cycle allowing for catalytic 
amounts of the metal to be employed and the potential to recycle the catalyst. 
 
Scheme 6 – Mechanism for a typical Suzuki reaction 
These classical cross-coupling reactions typically proceed via closely related mechanisms.  As an 
example, a Suzuki reaction starts with a Pd (0) species (21) typically obtained through a reduction of Pd 
(II) through a ligand association/dissociation process.  Phosphine or nitrogen based ligands are 
commonly used for these types of reactions.  This Pd (0) species (21) undergoes an oxidative addition 
into an aryl halide bond (22) forming a Pd (II) species.  This species then undergoes a ligand exchange 
followed by a transmetallation with the organometallic species (25).  Finally this bi-aryl palladium 
species (26) proceeds through a reductive elimination forming a new carbon-carbon bond between two 
aryl groups and regenerates the active Pd (0) species (21).  This regeneration of Pd (0) allows for the use 
of a catalytic amount of palladium.  Therefore, palladium is not consumed in the reaction and 
10 
 
theoretically can be reused indefinitely.  However, in practice, turnover of the palladium catalyst is 
limited, leading to a small amount of metallic waste. 
These characteristics and the advantages previously outlined have allowed the Suzuki reaction to attract 
significant interest from researchers and have led to its use in industrial applications.  Researchers at the 
Abbott process research and development laboratories have applied the use of a Suzuki reaction in their 
synthesis of ABT-869, a tyrosine kinase inhibitor.16  This molecule was found to have inhibitory effects on 
tyrosine kinase, which is essential in the process of angiogenesis associated with developing cancerous 
cells.  As such, this small molecule (30) was seen as a potential cancer therapeutic and the synthesis was 
scaled up to produce 100 kg. 
 
Scheme 7 – Abbott synthesis of ABT-869, a tyrosine kinase inhibitor 
This industrial synthesis of ABT-869 employed a late stage Suzuki reaction of advanced intermediate 
boronic ester (28) and chlorinated indazole (29).  The synthesis employed the use of 2 mol% of 
palladium acetate as a catalyst with 1,1’-Bis(diphenylphosphino)ferocene (dppf) as a ligand producing 
the desired inhibitor ABT-869 in a yield of 84% after purification.  As a by-product of the reaction, a 
borate salt is obtained and has a molar mass of 162.42 g/mol (31).  This by-product, discarded as waste, 
constitutes approximately 30% of the mass balance of the reaction, not including the use of additional 
                                                          
16
 Kruger, A. W.; Rozema, M. J.; Chu-Kung, A.; Gandarilla, J.; Haight, A. R.; Kotecki, B. J.; Richter, S. M.; Schwartz, A. 
M.; Wang, Z. Org. Process Res. Dev. 2009, 13, 1419. 
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reagents.  As such, the production of 100 kg of ABT-869 also produces an additional 30 kg of borate salt 
as by-product that would have to be subsequently disposed. 
A second example was performed in collaboration between the process laboratories of Merck Research 
Laboratories and Merck Frosst.  They describe an efficient scalable synthesis of a PDE4 inhibitor that 
could be used as a therapeutic for inflammation in the treatment of pulmonary diseases.17 
 
Scheme 8 – Merck’s synthesis of advanced intermediate (34) for the synthesis of a PDE4 inhibitor. 
Brominated intermediate (32), was reacted with boronic acid (33) under palladium catalysis conditions 
to provide advanced intermediate (34).  To minimize palladium leeching into the final product, Merck 
employed a strategy of using a carbon mounted palladium complex as a heterogeneous catalyst 
optimized from an original reaction employing Pd(OAc)2 as a homogeneous catalyst.  This strategy of 
employing a heterogeneous catalyst helps to facilitate the recycling of palladium.  After the reaction was 
completed, the mixture was filtered and the filter cake was washed, separating the solid palladium from 
the desired product in solution.  As with the synthesis of ABT-869 (Scheme 7), a borate salt is produced 
as a corresponding by-product of the reaction.  This synthesis demonstrates a slight increase in mass 
efficiency since the borate salt only composes 26% of the produced mass balance.17  Furthermore, the 
use of a heterogeneous catalyst decreases the environmental impact by minimizing palladium leeching 
                                                          
17
 Conlon, D. A.; Drahus-Paone, A.; Ho, G.-J.; Pipik, B.; Helmy, R.; McNamara, J. M.; Shi, Y.-J.; Williams, J. M.; 
Macdonald, D.; Deschênes, D.; Gallant, M.; Mastracchio, A.; Roy, B.; Scheigetz, J. Org. Process Res. Dev. 2006, 10, 
36. 
12 
 
into the reaction mixture.  This reduces the requirements for further subsequent purification steps to 
remove the metal contaminant.  
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Chapter 1.4 - C-H Activation 
Although the atom economy of the Suzuki reaction can be improved through the use of lower molecular 
weight boronic acids or boronic esters and less massive halogens or pseudo halides, the production of 
these boronate salts is an intrinsic limitation of the Suzuki reaction that cannot be overcome.  As such, 
recent developments in palladium cross-coupling chemistry have been focused on the elimination of the 
requirement for stoichiometric organometallic cross-coupling partners.  Pioneering work by the Fagnou 
research group at the University of Ottawa in 2004, demonstrated the intramolecular cross-coupling 
between an unactivated aryl group and an aryl bromide (36).18 
 
Scheme 9 – C-H activation of a tethered bi-aryl. 
This novel reactivity requires no organometallic component and produces no metallic waste other than 
the catalyst.  As such, this reaction demonstrates a step forward in the efficiency of palladium cross-
coupling reactions. 
Later that year, the intramolecular C-H activation of a tethered bi-aryl was applied towards the synthesis 
of aporphine alkaloids, which were found to have activity as serotonergic, dopaminergic, antiplatelet 
and vasorelaxing agents (Scheme 10).19 
 
                                                          
18
 Campeau, L.-C.; Parisien, M.; Leblanc, M.; Fagnou, K. J. Am. Chem. Soc. 2004, 126, 9186. 
19
 Lafrance, M.; Blaquière, N.; Fagnou, K. Chem. Comm. 2004, 2874. 
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Scheme 10 – C-H activation towards the synthesis of aporphine alkaloids 
Synthesis of these natural products further demonstrates the applicability and utility of this greener 
palladium cross-coupling reaction.  C-H activation was performed late in the synthesis demonstrating 
the ability for both cross-coupling partners to be carried through multiple step syntheses which is 
typically not facile for classical cross-coupling reactions. 
The scope of potentially reactive aryl halides was extended to aryl chlorides in the following years, by 
repeating the synthesis of tethered bi-aryl compounds.20  Optimized conditions were established using 
an N-heterocyclic carbene ligand resulting in the synthesis of 5 and 6 membered centre rings in high 
yields.  This method was subsequently applied towards the synthesis of allocolchicine, a microtubule 
depolymerisation agent that has potential as anti-tumour agents.21 
The synthesis of allocolchicine presented a new challenge to the application of C-H activation since it 
contained a difficult 7-membered medium sized ring (Scheme 11).  Previously, only 5 and 6 membered 
rings were prepared employing this chemistry.  Seven membered rings typically suffer from unfavorable 
entropic effects and produce ring strain, increasing the difficulty of formation.22  Entropic difficulties 
arise from changing the conformation of linear chains with high flexibility and rotation to a ring system 
that minimizes free rotation.  Enthalpic effects associated with ring strain are also a factor that must be 
overcome for the synthesis of these medium sized rings.  The ring conformation forces substituents to 
be closer in space, increasing steric hindrance for larger substituents.  As such, the synthesis of the 
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seven membered ring in allocolchicine represents a significant advancement in the field of direct 
arylation. 
 
Scheme 11 – Synthesis of allocolchicine from an advanced intermediate (41) 
Advanced intermediate (40) was synthesized in 5 steps with an overall yield of 54%.  This substrate was 
then subjected to direct arylation using Pd(OAc)2 as a palladium source and Davephos as a ligand, 
producing the desired 7-membered ring (41) in 94% yield.  The 7-membered ring was subsequently 
transformed into allocolchicine (42) over 4 steps with an overall yield of 39%.  This substrate 
demonstrated the versatility of direct arylation by synthesizing a difficult medium sized ring and also 
employing the use of chlorine as a halogen, which is typically less reactive than the corresponding 
bromide or iodide.  However, the chemistry is limited to tethered bi-aryl syntheses and can only be 
applied to intramolecular arylations. 
In 2006, a series of papers addressed the issue of tethered direct arylations allowing for the direct 
intermolecular arylation of 6-membered aromatic rings (Scheme 12).23  Optimizations of the reaction 
found that PivOH was an essential additive to the reaction increasing conversions from <5% to 
approximately 100%.  Furthermore, due to the typical inertness of aromatic hydrogens and potential for 
aryl bromide homocoupling, a large excess of benzene is required to obtain high yields.  The scope of 
the reaction was also determined, demonstrating high tolerance for a variety of aryl bromides 
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Scheme 12 – Intermolecular C-H activation of benzene 
The scope of the reaction is relatively broad and tolerant to different steric effects all in excellent yields.  
Electron-rich and -poor aryl bromides are also well tolerated in good to excellent yields.  Different 
halides however were less well tolerated; the typically more reactive iodide resulted in less than 10% 
yield and the aryl chlorides, which functioned excellently in intramolecular arylation, resulted in less 
than 5% yield.  Pivalic acid was found to play an important role helping with the deprotonation step and 
the metallation of the aryl group to generate a palladium bi-aryl species common to previous cross-
coupling reactions. 
Related to the mechanism for the Suzuki reaction (Scheme 6), the mechanism for C-H activation begins 
with a Pd (0) catalyst (21).  This Pd (0) species then undergoes an oxidative addition into an Ar-Br (22) 
bond providing a Pd (II) species (23).  Ligand exchange on Pd(II) occurs with pivalate generated through 
the deprotonation of pivalic acid.  Benzene then coordinates to the Pd (II) species (43) and the oxygen of 
pivalate then in a concerted mechanism undergoes a deprotonation and metallation.  This releases 
pivalic acid, which can be deprotonated to re-enter the cycle, and generates a bi-arylated palladium 
species (44).  This then undergoes reductive elimination regenerating the Pd (0) catalyst (21) and 
forming a C-C bond between two aryl species (45). 
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Scheme 13 – Proposed mechanism for C-H activation 
A competition experiment where an electron-rich anisole was reacted alongside benzene with para-
bromotoluene revealed that electron-rich aromatic rings undergo C-H activation less likely than 
electron-neutral aromatic rings.  Furthermore, electron deficient aromatics are preferentially arylated.  
However issues arise when these conditions are applied to aromatic compounds with multiple non-
equivalent hydrogens.  These reactive hydrogens allow for non-selective C-H activation leading to a 
mixture of products (Scheme 14). 
 
Scheme 14 – C-H activation of non equivalent hydrogens 
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C-H activation of anisole, containing different reactive hydrogens, with bromotoluene gives a mix of 
regioisomers.  The ratio obtained for meta and para-arylation, 50% and 25% respectively, suggests that 
electron donating substituents have little effect on the overall reactivity since the ratio obtained is 
consistent with the ratio of reactive hydrogens.  Ortho substitution, however, obtained in 22%, is the 
least reactive position and does not correspond to the ratio of hydrogens.  If the distribution of 
regioisomers was dependent solely on the ratio of hydrogens, a similar ratio for ortho and meta 
substitution would be expected.  This observation however can be explained through steric effects.  
Both pivalate and palladium need to coordinate to the hydrogen being deprotonated, thus an ortho 
substituent will cause steric repulsion effects to the large tert-butyl group present on the pivalate and 
the large phosphine ligands present on palladium.  This demonstrates that, although the regioselectivity 
of the reaction can be somewhat controlled through steric effects, mixtures of regioisomers will be 
obtained when more than one reactive hydrogen is present. 
The scope and utility of C-H activation was further expanded in 2009 to a variety of heteroaromatics 
with different aryl bromides (Scheme 15).24  This reaction was found to be effective for heteroaromatics 
of all types including thiophene, furan, N-substituted pyrroles, N-substituted imidazole, triazole, thiazole 
and oxazole and aryl bromides with various electron-donating and -withdrawing substituents.  However, 
the general scheme presented in the paper (Scheme 15, R=H) is slightly misleading as the 
heteroaromatic has reactive hydrogens on both the 2 and 5 position of the ring. 
 
Scheme 15 – C-H activation on heteroaromatics with aryl bromides 
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Having both C2 and C5 hydrogens present in a non symmetrical heteroaromatic would typically generate 
a mix of regioisomers resulting in mixtures of products and increasing the difficulty of purifications.  As 
such, to alleviate the problems with a lack of regioselectivity, Fagnou and co-workers employed the use 
of blocking groups at either position, reducing the reactive sites to one.  This strategy allows for 
selective C-H activation of a specific hydrogen without generating mixes of regioisomeric products. 
 
Scheme 16 – C-H activation of methyl thiophene-2-carboxylate (51) with 3-bromoanisole (52) 
As an example, the reaction of methyl thiophene-2-carboxylate (51) with 3-bromoanisole (52) gives 
mono-arylation at the 2 position since the 5 position of the thiophene is blocked with a methyl ester.  
This has proven to be an effective strategy for regioselective arylation and an improvement in the utility 
and applicability of C-H activation. 
Another solution to the regioselectivity issues attributed to C-H activation of heteroaromatics was 
presented by Doucet and co-workers in 2010.  Varying the steric environment at the C3 position allowed 
the influencing of C-H activation to the C2 or C5 positions.25 
 
Scheme 17 – Regioselective control using a C3 aldehyde 
With activated hydrogens at the C2 and C5 position of the furan, typically an equimolar amount of 
arylation would occur giving a mixture of regioisomers.  However, by varying substituents on C3, the 
regioselectivity of the reaction can be influenced.  Having a non-sterically encumbered aldehyde at C3 
                                                          
25
 Dong, J. J.; Doucet, H. Eur. J. Org. Chem. 2010, 611, 615. 
20 
 
allows for minimal steric interference and results typically in a 4 to 1 ratio of arylation favoring the C2 
position. 
Switching the C3 substituent to the bulkier acetal substituent increases steric interference and therefore 
the C2 position is less favourable for C-H activation.  Thus the regioselectivity of C-H activation can be 
reversed giving a 4 to 1 ratio in favour of the C5 position.  The acetal is subsequently hydrolyzed to 
reveal the aldehyde. 
 
Scheme 18 – Regioselective control using a C3 acetal 
Regioselectivity of C-H activation can be controlled through the use of different blocking groups 
minimizing reactive sites and through the use of different sterically hindered groups at the C3 position.  
However, these strategies suffer from limitations.  Installation of a blocking group at a desired position 
and timing can prove to be difficult in larger more complex molecules limiting the utility of this strategy.  
The use of different sterically hindered groups at C3 to direct arylation is also not an ideal strategy since 
it still results in a mixture of regioisomers and is typically difficult to purify. 
C-H activation has proven to be an effective method in arylation, requiring no pre-activation or the use 
of traditional organometallic cross-coupling partners reducing waste production.  This method has since 
been widely applied to a number of different aromatic and heteroaromatic substrates including total 
syntheses of natural products.  Strategies have also been developed to circumvent the limitations 
associated with regioselectivity through the use of blocking or directing groups.  However, these 
strategies suffer from limitations allowing for improvement in the area of green arylation without the 
use of organometallic cross-coupling partners.  
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Chapter 1.5 - Decarboxylative Cross-Coupling 
To address the common limitations associated with classical methods of cross-couplings, such as the 
production of stoichiometric metallic waste and the use of sensitive organometallic reagents, modern 
alternatives such as C-H activation were developed to alleviate these issues.  However, it also suffers 
from limitations with regioselectivity hindering applicability and versatility. To address these limitations 
associated with classical methods and C-H activation, alternative organometallic replacements have 
been investigated.  It was found that carboxylic acids could mimic the metal portion of an 
organometallic reagent, allowing for cross-couplings to occur.  Carboxylic acids are typically stable 
functional groups that can easily be protected as esters to be carried through multiple step syntheses, 
allowing for arylation at desired points in the synthetic route.  However, this intrinsic stability translates 
to a high energy barrier that has to be overcome to facilitate the reaction. 
An early example of a catalytic decarboxylative-cross coupling reaction was described by Myers and co-
workers in 2002.  They found that an aromatic carboxylic acid could be cross-coupled in a 
decarboxylative Heck type coupling with various olefins using a catalytic amount of palladium with silver 
carbonate (Scheme 19).26 
 
Scheme 19 – Myers decarboxylative Heck reaction 
Palladium sources were screened for their ability to promote decarboxylative coupling between 2,4,5-
trimethoxybenzoic acid and styrene.  They found that heating the mixture of the acid, styrene, palladium 
and copper (II) trifluoroacetate provided the desired product in 82% yield.  However, this reaction was 
found to be more difficult with less electron-rich carboxylic acids, where only recovered starting 
material was obtained.  As such, it was determined the decarboxylation step was the main difficulty of 
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the reaction.  Switching the base and additive to Ag2CO3 was found to be instrumental in improving the 
decarboxylation step.  This suggests the silver coordinates the carboxylic acid and lowers the energy 
barrier for decarboxylation (Scheme 20). 
 
Scheme 20 – Proposed mechanism for Myers decarboxylative Heck reaction 
The two metals in the reaction work in concert, starting with the silver coordinating to the carboxylic 
acid allowing a decarboxylation metallation sequence substituting silver for the carboxylic acid.  The 
subsequent aryl silver complex undergoes a transmetallation with palladium generating an aryl 
palladium species and a silver complex.  This aryl palladium then can coordinate the olefin and undergo 
a 1,2-insertion across the double bond.  This species then undergoes a β-hydride elimination giving the 
desired product and releasing the Pd (II) catalyst.  This reactivity allowed for the coupling of different 
aromatic carboxylic acids with different olefins however the process differs in mechanism and was not 
optimized for the cross-coupling of aromatics.  A general decarboxylative cross-coupling of aromatics 
could be envisioned to follow a similar strategy employing the use of a metal additive to facilitate 
decarboxylative metallation (Scheme 21). 
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Scheme 21 – General decarboxylative cross-coupling 
The aromatic carboxylic acid substituent could undergo a decarboxylative metallation, allowing the 
formation of an organometallic cross-coupling partner in situ and thus avoiding the need for pre-
activation.  This species could then undergo transmetallation with an aryl palladium complex generating 
a bi-aryl palladium species common to previous cross-coupling reactions leading to the formation of an 
aryl aryl bond.  Although the reaction is slightly less atom economical than C-H activation, the only by-
product of the reaction is carbon dioxide.  Furthermore, the production of carbon dioxide gas also 
makes the reaction irreversible and drives the reaction forward. 
In contrast to work performed by Myers, an early report by Steglich and co-workers demonstrated the 
intramolecular decarboxylative cross-coupling of two aryl groups for the synthesis of lamellarin L 
without the use of a metal additive.27  Lamellarin L is a hexacyclic alkaloid isolated from prosobranch 
mollusks that have been found to inhibit the growth of several tumor cell lines. 
 
Scheme 22 – Intramolecular decarboxylative cross-coupling in the synthesis of lamellarin L. 
An advanced intermediate (60) was heated with a stoichiometric amount of palladium acetate and a 
phosphine ligand at 150 °C for 80 min facilitating the decarboxylative cross-coupling between a tethered 
aryl bromide and a carboxylic acid present on the 2 position of the pyrrole.  Alternatively C-H activation 
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could also have been used; however, as demonstrated by Fagnou and co-works (Scheme 14) sterically 
hindered, ortho-substituted aryl halides typically generated the product in low yields.  Although a 
stoichiometric use of palladium for cross-coupling reactions is not ideal, this example represented a 
proof of principle for the development of a catalytic decarboxylative cross-coupling reaction without the 
use of metal additives. 
Utilizing principles demonstrated by Myers in the decarboxylative Heck reaction and Steglich in the 
synthesis of lamellarin L, carbon-carbon bond forming reactions between two aryl groups using a 
decarboxylative cross-coupling was established by three different groups around the same time.  The 
works of Gooßen and co-workers focused primarily on the decarboxylative cross-coupling of benzoic 
acids using a copper palladium system, the group of Becht employed a silver palladium system and the 
group of Forgione and Bilodeau focused primarily on the decarboxylative cross-coupling of 
heteroaromatic carboxylic acids with palladium. 
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Chapter 1.6 - Gooßen decarboxylative cross-coupling 
Decarboxylation of benzoic acids using copper was initially established by Nilsson and co-workers in 
1966.  They described an aryl copper species that was captured with an excess amount of iodobenzene, 
producing bi-phenyl products.28  Since Ullmann-type chemistry had intrinsic limitations such as low 
selectivity for heterocoupling and uses stoichiometric amounts of copper, Gooßen and co-workers 
envisioned the use of a bi-metallic catalyst system to facilitate decarboxylative cross-coupling.  In 2006, 
they described a decarboxylative cross-coupling of benzoic acids with aryl bromides to generate bi-
phenyl motifs.29,30  Bi-phenyls were a common motif among some of the top selling drugs of the time, 
demonstrating the importance and potential impact of this transformation.  Using a bi-metallic catalyst 
system employing copper and palladium, it was found the copper would initially coordinate with the 
carboxylic acid to facilitate decarboxylation to form an aryl copper bond.  This aryl copper species then 
undergoes a transmetallation with palladium (II) generating a di-arylated palladium species, a common 
intermediate of cross-coupling reactions.  Optimization studies of the decarboxylative cross-coupling 
reaction using 2-nitrobenzoic acid (62) and 4-bromochlorobenzene (63) as a model reaction was 
evaluated, which could be used towards the synthesis of Boscalid. 
 
Scheme 23 – Synthesis of Boscalid intermediate using decarboxylative cross-coupling 
Formation of the desired bi-aryl compound (64) was not observed when heated with a palladium source 
and a phosphine ligand, nor was it observed when just heated with a copper (II) source in the absence of 
palladium.  The combination of both metals proved to be effective in the synthesis of the desired bi-
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aryls and optimization of the reaction conditions were then performed.  They found that Pd(acac)2, P(i-
Pr)Ph2, CuCO3, KF and molecular sieves in NMP to be the optimal conditions.  However, the 
stoichiometric use of Cu(II) was undesirable and as such optimizations for the use of sub-stoichiometric 
amount was attempted.  The active copper species could theoretically be regenerated after 
transmetallation with the palladium allowing for a catalytic amount of copper to be used.  This however 
was found to be unsuccessful as the Cu (II) species would irreversibly reduce to Cu (I) which proved to be 
unreactive under these conditions.  As such, the conditions were re-optimized using the less reactive Cu 
(I) species at an increased temperature.  The optimal conditions, CuI (1 mol%), Pd(acac)2 (0.5 mol%) and 
phenanthroline (3 mol%) in NMP, was then applied to a variety of aryl carboxylic acids and coupled with 
aryl bromides. 
 
Scheme 24 - Gooßen decarboxylative cross-coupling mechanism 
Bearing some similarities to the decarboxylative Heck reaction described by Myers, the decarboxylative 
cross-coupling reaction requires the use of two metals in the mechanism, but in catalytic amounts 
rather than stoichiometric.  Similar to the silver used by Myers to facilitate decarboxylation, Gooßen 
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employed the use of a copper species for a similar purpose.  A copper (I) species was shown to be more 
stable than either copper (II) sources or silver and as such the decarboxylation requires higher 
temperatures to occur.  Copper (I) undergoes an anion exchange with the carboxylate and subsequently 
facilitates a decarboxylation metallation giving an aryl copper species.  This then undergoes a 
transmetallation with an aryl palladium (II) species that was generated through the oxidative addition 
into the aryl halide bond.  Transmetallation regenerates the active copper species and produces a 
diarylated palladium (II) complex.  This complex then undergoes reductive elimination producing the 
desired aryl aryl bond and regenerating palladium (0). 
The use of a catalytic amount of metal for decarboxylation proves to be advantageous in minimizing the 
amount of copper required for reactivity.  This regeneration of copper also reduces the amount of 
metallic waste produced and as such renders the reaction more environmentally friendly.  The scope of 
this method for the formation of bi-aryls was later expanded to α-oxocarboxylates,31 chlorides32 and 
tosylates.33 
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Chapter 1.7 - Becht decarboxylative cross-coupling 
In 2007, Becht and co-workers developed a decarboxylative cross-coupling reaction between a variety of 
benzoic acids and aryl iodides.34  They employed the use of silver to help facilitate decarboxylation and 
metallation.  The aryl silver species subsequently undergoes a transmetallation with palladium and to 
facilitate the cross-coupling. 
 
Scheme 25 – Becht decarboxylative cross-coupling 
Becht and co-workers employed the use of silver carbonate to serve a dual purpose, acting as both a 
base and to co-ordination to the carboxylic acid and facilitate decarboxylation.  Similar to previously 
reported palladium catalyzed decarboxylative cross-coupling reactions elevated temperatures were 
required to overcome the intrinsic stability of carboxylic acids.  Optimizations of the palladium source 
and ligand found that palladium chloride was optimal but required loadings of 30 mol%.  Lower 
palladium loadings were found to be detrimental to the yield of the desired cross-coupling product.  
Initial results employing phosphine-based ligands gave moderate yields and optimizations with a variety 
of ligands found that triphenylarsine was the preferred ligand.  Similar to the mechanism presented by 
Gooßen (Scheme 20) silver was employed to facilitate the decarboxylation of benzoic acids (65).  The 
aryl silver species then undergoes a transmellation with an aryl bound palladium (II) species, generating 
a bis-arylated palladium (67).  This species then undergoes a reductive elimination, regenerating the 
palladium (0) catalyst and forming the carbon-carbon bond. 
This method gave a wide range of substituted bi-aryl products from good to excellent yields. However, 
the requirement for high palladium and ligand loadings were not ideal from an environmental 
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perspective limiting industrial applications of this process.  As such, focus was placed on the more 
efficient Gooßen decarboxylative cross-coupling and the Forgione and Bilodeau decarboxylative cross-
coupling reactions.  
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Chapter 1.8 - Forgione and Bilodeau decarboxylative cross-coupling 
A different decarboxylative cross-coupling was developed by Forgione and Bilodeau at Boehringer 
Ingelheim in 2006, which formed carbon-carbon bonds between heteroaromatic and aromatic 
compounds.35 
 
Scheme 26 – Forgione and Bilodeau decarboxylative cross-coupling 
Similar to the previous decarboxylative cross-coupling reactions, an aromatic carboxylic acid was reacted 
with an aryl halide with palladium to generate a new carbon-carbon bond.  Although this reaction is a 
related decarboxylative cross-coupling there are significant differences from the previous bi-metallic 
systems.  The only metal present in the reaction is palladium which suggests a different mechanism for 
decarboxylation.  Another significant difference is the short reaction times for this reaction compared to 
alternatives and the use of microwave heating rather than conventional thermal heating.  The final 
major difference is the use of tetrabutylammonium chloride as an additive that was found to minimize 
unwanted C3 arylation.  Having only catalytic equivalents of a single metal present in the reaction and 
the observation of a bis-C2 and C3 arylated product, Forgione and Bilodeau proposed a mechanism to 
explain these observations.36 
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Scheme 27 – Forgione and Bilodeau decarboxylative cross-coupling mechanism 
The mechanism starts with a Pd (0) complex (21) which undergoes oxidative addition into an aryl 
bromide bond (22).  Anion ligand exchange with the palladium (II) species (23) then occurs producing a 
palladium carboxylate species (69).  From this intermediate (69), three different potential pathways 
were possible; path A: direct extrusion of CO2, path B: C2 electrophilic palladation and path C: C3 
electrophilic palladation.  Path A, a direct extrusion of CO2 would allow for immediate C2 palladation 
(71) that could undergo reductive elimination, regenerating palladium (0) (21) and giving the desired 
product (72).  This pathway however was believed to not be the mechanism of action since it does not 
make use of the heteroatom present in the aromatic ring that was shown to be essential for this 
transformation.  Direct extrusion of CO2 would also allow benzoic acids to be reactive substrates under 
these conditions, however they were found to not be reactive, supporting an alternative mechanistic 
pathway.  Pathway B employed the use of the heteroatom present in the ring to facilitate a C2 
electrophilic palladation (71).  This could then undergo irreversible decarboxylation to restore 
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aromaticity and generate the same diarylated compound formed in pathway A.  This intermediate then 
undergoes reductive elimination to form a new carbon-carbon bond.  The final pathway, path C, was 
proposed based on a by-product isolated from the reaction.  C3 electrophillic palladation was found to 
occur which can be explained through the delocalization of electrons from the heteroatom.  If the C3 
substituent is hydrogen, this can be deprotonated to regenerate aromaticity giving rise to a C3 
palladium aryl species.  This then undergoes reductive elimination to regenerate palladium (0) (21) and 
form a C3-aryl bond (75) leaving the carboxylate present, which can re-enter the catalytic cycle and 
undergo subsequent arylation at C2, providing the observed 2,3-diarylated by-product. 
This decarboxylative cross-coupling represents a more efficient and greener process than the previously 
mentioned methods since it employs low palladium loadings and does not require a second metal as a 
base or a co-catalyst.  This method also employs microwave heating over traditional thermal heating for 
short reaction times, which consumes less energy.  Forgione, Bilodeau and co-workers elaborated on the 
scope of the reaction demonstrating with a variety of heteroaromatic, aryl halides and pseudo halides.36 
Further demonstrating the efficiency and applicability of this reactivity, work by Mitchell and co-workers 
applied this chemistry towards the industrial synthesis of an important key intermediate for an 
undisclosed drug synthesis.37 
 
Scheme 28 – Mitchell generation 1 synthesis of key intermediate 
The generation 1 synthesis started from 4-bromophenyl-ethylacetate (76) and after 6 steps, key 
intermediate (77) was generated in an overall yield of 34%.  As a low yielding process, this synthesis 
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generated significant amounts of waste and by-products that was not desired from both an industrial 
and environmental perspective.  Due to these factors, Mitchell and co-workers explored various options 
for the synthesis of the key intermediate (77).  They found that starting with 3-aminothiophene-2-
carboxylate they could undergo a decarboxylative cross-coupling with an aryl halide to efficiently 
generate the desired key intermediate in a single step. 
 
Scheme 29 – Mitchell generation 2 synthesis of key intermediate 
Optimizations of a decarboxylative cross-coupling between carboxylate (78) and 4-chloro 
bromobenzene produced the desired key intermediate (77) in a 98% yield.  When compared to the 6 
step 34% yield generation 1 synthesis, the amount of waste produced is dramatically reduced and the 
efficiency of the process is increased.  Furthermore, the synthetic route was reduced from 6 steps to a 
single step which allowed greater access of the desired key intermediate (77). 
Decarboxylative cross-coupling has proven itself as a green alternative to classical cross-coupling 
methods.  It also circumvents the limitations associated with C-H activation and has been proven to be 
effective on an industrial scale.  However, decarboxylative cross-coupling is a relatively novel reaction 
that requires further development and applications. 
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CHAPTER 2 – RESULTS AND DISCUSSION 
Chapter 2.1 – Project introduction 
Thienoisoquinoline systems have been found to have interesting biological activity as a potential breast 
cancer therapeutic.1  However, these heterocyclic tricycles are scarcely reported in the literature and 
present an interesting area of potential research opportunity.  Furthermore, designing novel syntheses 
of these compounds should employ the principles of green chemistry to facilitate sustainable syntheses 
of these important molecules. 
 
Figure 3 – Thienoisoquinolines 
Previous structure activity relationship and biological activity studies performed by Wyeth in 20061 
demonstrated the inhibitory activity of functionalized thienoisoquinolines against estrogen receptor 
NFκB. 
 
Figure 4 – Example of estrogen receptor NFκB inhibitors 
Inhibition of this receptor can lead to potential therapeutics for the treatment of breast cancer, 
inflammation associated with congestive heart failure, inflammatory bowel disease and arthritis. 38  
Other potential therapeutic areas include type II diabetes,39 osteoarthritis,40 asthma,41 Alzheimer’s 
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disease, and autoimmune diseases.1,42  Thus the synthesis of these compounds presents an important 
area of research with unexplored potential.  Previously, there has only been a single report of the 
synthesis of 3,4-thienoisoquinolines48 and a few reports of 2,3-thienoisoquinolines.1  However, previous 
syntheses of these compounds did not facilitate functionalization and typically employed harsh synthetic 
conditions or lengthy syntheses.  Therefore a retrosynthesis of the two isomers was envisioned from a 
single common intermediate which would allow for easy access of either functionalized 
thienoisoquinoline isomer. 
 
Scheme 30 – Retrosynthesis of both thienoisoquinolines 
The 3,4-thienoisoquinoline isomer (4) can be functionalized from the versatile carboxylic acid through a 
variety of transformations.  The carboxylic acid (3) can undergo protodecarboxylation or arylated using a 
decarboxylative cross-coupling reaction.  Furthermore, it can be functionalized to a bromine through a 
Hunsdiecker reaction or to an amine employing a Curtius rearrangement.  The carboxylic acid (3) can be 
obtained through the saponification of the corresponding ester.  The thienoisoquinoline system could 
then be obtained through an intramolecular C-H activation on the typically less reactive C4 position and 
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functionalization at C5 can also be obtained through a C-H activation reaction.  This C4-H activation 
could be facilitated due to the blocking group employed on the C2 position preventing arylation.  
Furthermore, the formation of a 6-membered ring through an intramolecular process should be favored 
over intermolecular C5-arylation.  3,4-thienoisoquinolines could be obtained through the C4-H 
activation of the common intermediate (2) which can be obtained through the benzylation of the 
corresponding functionalized amine.  The functionalized amine can also be obtained from the 
corresponding primary amine (1).  The regioselectivity of the C-H activation of the common intermediate 
(2) can be controlled through the use of blocking groups.  C-H activation can occur in the presence of an 
external aryl bromide selectively due to the differences in reaction rates of intramolecular and 
intermolecular reactions.  The use of a blocking group at C2 removes the potentially reactive hydrogen 
that typically would lead to a mixture of products. 
Similarly functionalized 2,3-thienoisoquinolines (7) can be obtained through derivatization of the C5 
position through C-H activation or bromination reactions of the unfunctionalized thienoisoquinoline (6).  
The thienoisoquinoline (6) can be obtained through the decarboxylative cross-coupling of the 
corresponding carboxylic acid which could be obtained through the saponification of the ester of the 
common intermediate (2).  The common intermediate (2) can be obtained as previously described.  
Decarboxylative cross-couplings were shown to react selectively between a carboxylic acid and an aryl 
halide in the presence of reactive hydrogens that can undergo C-H activation.35  This reactivity would 
lead to the synthesis of 2,3-thienoisoquinolines employing the ester functionality as a synthetic handle 
rather than a blocking group as with the synthesis of 3,4-thienoisoquinolines.  
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Chapter 2.2 – Synthesis of the key intermediate 
The goal of the project was to develop and optimize a synthetic route towards the two isomers of these 
heterocycles.  For either of the desired isomer, synthesis of the key intermediate (2) was important.  
Also important to this process was the ease of large scale synthesis and environmentally friendly 
purification that would allow for timely access of key intermediate (2), allowing efforts to be focused on 
optimizing cross-coupling reactions in the synthesis, the development of the double C-H activation 
reaction and the decarboxylative cross-coupling reaction.  The synthesis of the key intermediate was 
envisioned to begin from a commercially available thiophene. 
 
Figure 5 – Commercially available starting material 
A survey of commercially available functionalized thiophene derivatives that could be employed as 
starting material for the synthesis resulted in methyl-3-aminothiophene-2-carboxylate (1).  This 
commercially available thiophene contained an easily functionalizable primary amine and an ester group 
present at C2 that could serve the dual purpose of a blocking group and be used as a synthetic handle.  
With a commercially available starting material determined, initial steps towards the synthesis of the 
key intermediate (2) were undertaken.  The first step was the functionalization of the primary amine 
with groups similar to the biologically active compounds published by Wyeth. 
 
Scheme 31 – Proposed synthesis of key intermediate (2) 
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The synthesis was envisioned to start with the sulfonylation of commercially available methyl 3-
aminothiophene-2-carboxylate (1) resulting in the desired sulfonamide (78).  This intermediate could 
then be benzylated with various substituted benzyl halides giving the desired key intermediate (2).  
Initial attempts at functionalization of the primary amine with a sulfonyl-chloride were made following a 
procedure by Saibal and co-workers.43  They described a neat reaction employing heating through 
microwave irradiation resulting in sulfonamide formation in short reaction times. 
 
Scheme 32 – Microwave sulfonamide synthesis 
The procedure was initially appealing from a green perspective since it did not require the use of any 
solvent and had low reaction times.  However, these conditions were unsuccessful and the reaction was 
found to not occur.  The crude mixture was analyzed by proton NMR and signals which could be 
attributed to the product were not observed.  Typically a solvent is used in a reaction to solubilise 
reactants allowing for improved molecular contact.  However, in a neat reaction, typically one or more 
of the reactants acts as the solvent to facilitate the reaction.  Although para-toluenesulfonyl chloride 
was liquid under the reaction conditions, it is probable that the HCl by-product produced in the reaction 
would protonate the primary amine and reduces the nucleophilicity of the amine.  Further difficulty in 
the reaction can be found in the nucleophilicity of the primary amine.  Since the heteroaromatic ring 
contains an electron withdrawing ester substituent that draws electron density away from the ring and 
in turn reducing the nucleophilicity of the amine. 
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To overcome the poor nucleophilicity of the amine, one equivalent of sodium hydride, a strong base, 
was used to deprotonate the amine and to form the highly nucleophilic amine anion.  When considering 
the pKa of H2 (~36), the conjugate acid of sodium hydride, and the pKa of an aromatic amine (~31),
44 the 
first deprotonation of the primary amine is favoured which should lead to the desired amine anion 
nucleophile. 
 
Scheme 33 – Sodium hydride as a base in sulfonamide synthesis 
Unfortunately the addition of a strong base gave unexpected results and resulted in the decomposition 
of the starting materials to a complex mixture of products was found to occur.  Since initial attempts 
were unsuccessful, a more extensive survey of current literature was performed to search for milder 
reaction conditions, revealing a procedure by Tondi and co-workers.45 
 
Scheme 34 – Optimizations of sulfonamide synthesis 
This procedure employed the use of pyridine both as a base and as a solvent.  The initial nucleophilic 
attack of the primary amine on the sulfonyl-chloride would result in cationic amine which was 
neutralized by pyridine resulting in the desired product.  Initial efforts employing literature conditions 
proved to be successful, resulting in an isolated yield of 53%.  Although this procedure gave the desired 
sulfonamide (78a), the moderate yield obtained was not practical for large scale synthesis of these early 
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intermediates.  Optimizations were attempted, increasing the equivalents of sulfonyl-chloride used.  It 
was found that at 1.5 equivalents was optimal and the desired product could be isolated in a 88% yield.  
Furthermore, the reaction was performed on a multigram scale and purified through recrystalization.  
The ability to perform the reaction on multigram scale demonstrates the potential for future industrial 
development.  Also purification through recrystalization rather than traditional purification methods 
such as column chromatography not only presents a more environmentally friendly alternative but 
further demonstrates the possibility for industrial scale synthesis.  Column chromatography employs 
large quantities of silica gel and solvent that on industrial scale syntheses are impractical.  
Recrystalization presents an alternative purification that does not require silica gel and uses less solvent.  
With an increased yield and established purification methods, these optimized conditions were applied 
to a variety of sulfonyl-chlorides. 
 
Entry Ar Yield (%) 
1 4-CH3C6H4 83 
2 3-CH3C6H4 83 
3 2-CH3C6H4 92 
4 4-MeOC6H4 81 
5 4-FC6H4 65 
6 4-NO2C6H4 46 
7 2-thiophene 69 
Table 1 – Scope of sulfonamide synthesis 
A variety of sulfonyl-chlorides were used to synthesize sulfonamides (78), in modest to excellent yields.  
Different sterically demanding substituents (Table 1, entries 1-3) were synthesized in good to excellent 
yields.  Similarly electron rich aromatic rings (Table 1, entry 4) were well tolerated.  Electronically poor 
aromatic rings (Table 1, entries 5, 6) however were less successful generating the sulfonamides (78) in 
modest yields.  Finally, heteroaromatic substituents were also tolerated in good yields.  With optimized 
41 
 
conditions established for sulfonamide synthesis and the scope of the reaction explored, benzylation of 
sulfonamides were attempted.  Sulfonamides (78), were then subjected to benzylation conditions 
reported by Becalli and co-workers.46 
 
Scheme 35 – Benzylation using sodium hydride as base 
Similar to the synthesis of sulfonamides (Scheme 33), sodium hydride was used as a strong base in 
efforts to deprotonate the sulfonamide and increase nucleophilicity for subsequent benzylation.  
However, the desired reaction was found to not occur, giving a complex mixture of products.  Thus a 
survey of the literature was performed revealing a procedure by Fawzi and co-worker which employed 
the use of potassium carbonate as a base with dimethylformamide as a solvent.47 
 
Scheme 36 – Optimization of benzylation reaction 
Although initial attempts proceeded in a good yield of 81%, minor optimizations were attempted by 
increasing the equivalents of benzyl bromide.  The addition of 1.2 equivalents of benzyl-bromide was 
found to slightly increase the yield to 92%.  After reaction optimization, different purification methods 
were attempted.  The original purification method employing silica gel chromatography was replaced by 
recrystalization allowing for multigram syntheses and greater potential for industrial application.  With 
                                                          
46
 Beccalli, E. M.; Broggini, G.; Martinelli, M.; Sottocornola, S. Synthesis 2008, 1, 136. 
47
 Coppo, F. T.; Fawzi, M. M. J. Heterocyclic Chem. 1998, 35, 983. 
42 
 
conditions established for the synthesis of the key intermediates (2), the scope of the reaction was 
explored. 
 
Entry X Y T (°C) Yield (%) 
1 Br H 50 92 
2 Cl H 80 87 
3 Cl F 80 99 
4 Cl Cl 80 83 
Table 2 – Scope of benzylation reaction 
Benzylation can be extended to chloro-benzyl-halides by increasing the reaction temperature to 80 °C.  
Different ortho-substituents were found to be well tolerated by the reaction conditions generating good 
to excellent yields (entries 3, 4) similar to benzyl-bromides (entry 1).  With a variety of key intermediates 
synthesized, efforts were made towards the synthesis of 3,4-thienoisoquinolines and the optimization of 
a double C-H activation reaction. 
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Chapter 2.3 – Synthesis of 3,4-thienoisoquinolines 
A survey of the literature revealed only a single synthesis of these important compounds reported by 
Bogza and co-workers in 2009.48  However, the reported synthesis was specific for a single 3,4-
thienoisoquinoline system and not designed for library synthesis.  Furthermore, the synthesis required 
the use of harsh acidic conditions to facilitate cyclization.  Therefore, the application of this method on 
an industrial scale or for small molecule inhibitor development was not ideal. 
 
Scheme 37 – Bogza synthesis of 3,4-thienoisoquinolines 
The previous synthesis employed the use of advanced intermediate (79) heating in trifluoro-acetic acid 
for an extended period of time.  These harsh acidic conditions resulted in low functional group tolerance 
and would be difficult for large scale applications.  As such, a synthesis employing less harsh conditions 
was envisioned employing palladium catalysis to form multiple bonds in a single step. 
 
Scheme 38 – Double C-H activation reaction towards the synthesis of 3,4-thienoisoquinolines. 
In the development of a double C-H activation reaction, initial conditions were derived from the 
intermolecular C-H activation of heteroaromatics reported by Fagnou and co-worker.49  Subjecting key 
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intermediate (2a), to palladium catalysis conditions with the addition of 3-bromo-anisole was found to 
give the desired thienoisoquinoline (81a) without the requirement for further optimization.  The 
thienoisoquinolines were identified using NMR analysis and further evidence of the synthesis of these 
compounds by double C-H activation was provided by X-ray crystallography. 
 
Figure 6 – X-ray structure of a substituted 3,4-thienoisoquinoline 
The X-ray structure of a substituted 3,4-thienoisoquinoline (Table 3, entry 7) clearly portrays the two 
arylations.  An intramolecular C-H activation at C4 generating the unfunctionalized 3,4-
thienoisoquinoline and the arylation at C5.  Thus, with optimized conditions established and 
identification of these compounds, the scope of the reaction was explored employing various 
sulfonamides, aryl bromides and benzyl substituents.50 
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Entry Ar R X R
2
 Yield (%) 
1 4-Me-C6H4 H Br C6H5 64 
2 4-Me-C6H4 H Br 3-MeO-C6H4 99 
3 4-Me-C6H4 H Br 4-MeO-C6H4 90 
4 4-Me-C6H4 H Br 3-EtOOC-C6H4 97 
5 4-Me-C6H4 H Br 4-EtOOC-C6H4 81 
6 3-Me-C6H4 H Br 3-MeO-C6H4 80 
7 2-Me-C6H4 H Br 3-MeO-C6H4 81 
8 4-MeO-C6H4 H Br 3-MeO-C6H4 79 
9 4-F-C6H4 H Br 3-MeO-C6H4 90 
10 4-Me-C6H4 H Br H 96 
11 4-Me-C6H4 H Cl 3-MeO-C6H4 0 
12 4-Me-C6H4 F Cl 3-MeO-C6H4 0 
13 4-Me-C6H4 Cl Cl 3-MeO-C6H4 0 
Table 3 – Scope of double C-H activation reaction 
The reaction was found to work with a large variety of Ar2 substituents with different steric 
encumbrance (entries 1-7) and with a variety of electronically differing aryl bromides.  Most aryl 
bromides were well tolerated giving excellent yields.  However, bromobenzene (Table 3, entry 1) was 
found to proceed in lower yields.  Furthermore, different sulfonamide substituents were well tolerated 
resulting in good to excellent yields for electronically neutral (Table 3, entries 2, 6-7), donating (Table 3, 
entry 8) and withdrawing (Table 3, entry 9) substituents.  This reaction was also found to proceed in 
excellent yields in the absence of an external aryl bromide.  Unfortunately, under the reaction 
conditions, aryl chlorides were found to be unsuitable cross-coupling partners resulting in 0% isolated 
yields (entries 11-13).  Overall, double C-H activation was found to occur for a wide scope of substrates. 
Although the mechanism of this transformation has not been studied, a proposed mechanism can be 
established based on previous work on C-H activation by Fagnou and co-workers.23 
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Scheme 39 – Proposed mechanism for double C-H activation reaction 
The mechanism can be envisioned as a continuous cycle where the product of the first C-H activation 
can undergo C-H activation through the second cycle.  Palladium undergoes oxidative addition into the 
aryl bromide bond of the key intermediate (2).  This then undergoes an anion exchange followed by a 
concerted metallation deprotonation sequence to form a 7-membered palladacycle (91). Finally this 
palladacycle undergoes reductive elimination regenerating the palladium (0) catalyst (21) and 
generating an unsubstituted 3,4-thienoisoquinoline (81b).  The catalyst either continues in the 
intramolecular C-H activation cycle or undergoes intermolecular C-H activation.  Similarly the 
intermolecular C-H activation follows the same sequence of steps.  First an oxidative addition into the 
external aryl bromide bond can occur, then anion exchange and a concerted metallation deprotonation 
sequence with the C5-H of the unsubstituted 3,4-theinoisoquinoline (81b) occurs.  The metallated 
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intermediate (85) finally undergoes reductive elimination forming the desired carbon-carbon bond and 
regenerate the palladium (0) catalyst. 
With the desired 3,4-thienoisoquinolines prepared, focus was placed on the functionalization of these 
systems using the masked carboxylic acid at C2.  Unmasking the carboxylic acid would allow 
functionalization through a variety of reactions such as protodecarboxylation to remove the acid, 
decarboxylative cross-coupling to introduce an aryl group, Hunsdiecker reaction for bromination and a 
Curtius rearrangement for amination.  Focusing on metal catalyzed reactions, the acid was unmasked 
and was subjected to protodecarboxylation conditions.  Fortunately, the first set of conditions 
attempted, derived from Forgione and Bilodeau, proved to be successful generating the product in 
modest to good yields.35 
 
Entry Ar Ar
2
 Yield (%) 
1 4-Me-C6H4 C6H5 55 
2 4-Me-C6H4 3-MeO-C6H4 65 
3 4-Me-C6H4 4-MeO-C6H4 78 
4 4-Me-C6H4 3-HOOC-C6H4 84 
5 4-Me-C6H4 4-HOOC-C6H4 70 
6 3-Me-C6H4 3-MeO-C6H4 69 
7 2-Me-C6H4 3-MeO-C6H4 70 
8 4-MeO-C6H4 3-MeO-C6H4 68 
9 4-F-C6H4 3-MeO-C6H4 78 
Table 4 – Scope of protodecarboxylation reaction 
Palladium coordinates to the carboxylic acid and helps to lower the activation energy barrier facilitating 
protodecarboxylation.  Protodecarboxylation occurred for a variety of electronically demanding 
substituents for Ar and Ar2 with a large substrate scope.  The most surprising results were entries 4 and 
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5 where Ar2 was substituted with a carboxylic acid.  Under these specific conditions, only the desired 
heteroaromatic carboxylic acid was decarboxylated without affecting the Ar2 carboxylic acid substituent. 
With conditions for protodecarboxylation established and scope explored, decarboxylative cross-
coupling was explored as a second reaction to functionalize at the C2 position.  Initial attempts were 
made using conditions for protodecarboxylation with the addition of an aryl bromide cross-coupling 
partner. 
 
Scheme 40 – Initial attempt at decarboxylative cross-coupling 
Unfortunately, these conditions failed to give the desired product, instead resulting in significant 
protodecarboxylation of the substrate.  As such, optimizations of palladium source, ligand, additives, 
temperature and equivalents of Ar-Br were performed in efforts to increase the yield of the 
decarboxylative cross-coupling. 
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Entry Pd source Ligand Additive T (°C) t (h) Equiv. Ar-Br Yield (%) 
1 PdCl2 (5 mol%) dppf (6 mol%) TBAB (15 mol%) 80 3 1 0 
2 PdCl2 (5 mol%) dppf (6 mol%) TBAB (15 mol%) 100 3 1 22 
3 PdCl2 (5 mol%) dppf (6 mol%) TBAB (15 mol%) 120 3 1.5 0 
4 Pd(OAc)2 (5 mol%) dppf (6 mol%) TBAB (15 mol%) 120 1 1.5 0 
5 Pd(OAc)2 (5 mol%) P
t
Bu3HBF4 (6 mol%) TBAB (15 mol%) 120 3 1.5 0 
6 PdCl2 (5 mol%) dppf (6 mol%) TBAC (15 mol%) 100 1 1.2 0 
7 PdCl2 (10 mol%) CH3CN (12 mol%) TBAB (15 mol%) 100 1 1.2 17 
Table 5 – Optimizations of decarboxylative cross-coupling reaction 
Initial screenings found that protodecarboxylation occurred more readily at higher temperatures 
decreasing cross-coupling.  Therefore, initial changes to reduce temperature were attempted.  However, 
reducing the temperature to 80 °C (Table 5, entry 1) proved to be very detrimental to the reaction and 
resulted in no product formation.  Increasing the temperature to 100 °C (Table 5, entry 2) resulted in a 
slight increase in yield however further increase in temperature (Table 5, entry 3) resulted in 
protodecarboxylation and no product formation.  Similarly, changing the palladium source (Table 5, 
entry 4), ligand (Table 5, entry 5), or additive (Table 5, entry 6) resulted in no product formation.  It was 
then hypothesized that the nitrile of the Ar-Br was coordinating to palladium and mimicking a ligand and 
reducing reactivity.  Acetonitrile was added as a ligand (Table 5, entry 7) and resulted in some reactivity 
giving 17% yield.  Further attempts at the optimization of reaction conditions proved to be unsuccessful. 
In summary, a robust method to synthesize 3,4-thienoisoquinolines from commercially available starting 
materials was established.  The 3 step synthesis to access these heterocycles employed the use of a 
double C-H activation reaction which allows for quick diversification of aromatic substituents at the C5 
position of thiophene.  Furthermore, the methyl ester present at the C2 position can be unmasked 
revealing a carboxylic acid moiety which can be protodecarboxylated.  Initial work demonstrated that 
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the carboxylic acid can undergo decarboxylative cross-coupling however further optimizations were 
necessary.  Other unexplored functionalization of the carboxylic acid can include bromination through a 
Hunsdiecker reaction or amination through a Curtius rearrangement.  Although more functionalization 
could be explored, efforts were focused on the synthesis of the other isomer of thienoisoquinolines.  
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Chapter 2.4 – Synthesis of 2,3-thienoisoquinolines 
Similar to 3,4-thienoisoquinolines, the 2,3-thienoisoquinoline isomer was scarcely reported in the 
literature but has recently gained significant attention due to its potential as a therapeutic against 
breast cancer.1  Previous syntheses of these compounds relied on the synthesis of the thiophene itself51 
limiting the ease of late stage diversification.  Other syntheses required the use of fused thiophene 
bicycles46,52,53 limiting diversification.  One synthesis focusing on synthesizing a library of these 
compounds for SAR purposes was reported by Wyeth.1 
 
Scheme 41 – Wyeth synthesis of substituted 2,3-thienoisoquinolines 
The Wyeth synthesis starts with commercially available thiophene-3-carboxylate (86) that undergoes a 
Curtius rearrangement in tBuOH generating the Boc protected amine (87).  The thiophene is then 
brominated at C2 selectively using NBS.  Brominated thiophene (88) then undergoes a Suzuki coupling 
reaction followed by imine formation and aromatization.  Imine (89) was then reduced to the secondary 
amine (90) which was substituted with various sulfonyl-chlorides.  Sulfonamide (6) was brominated at 
C5 to facilitate a second Suzuki reaction to introduce various C5-aryl substituents.  Although this 
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synthesis allows for the late stage diversification at the C5 position, the requirement of a two-step 
arylation extends the length of the synthesis.  Furthermore, arylation is limited by the amount of 
commercially available boronic acid cross-coupling partners.  Therefore, an alternative synthesis was 
envisioned to shorten the number of synthetic steps and increase the potential for diversification at the 
C5 position. 
 
Scheme 42 – Proposed synthesis of 2,3-thienoisoquinolines 
From previously synthesized key intermediate (2), the acid can be unmasked revealing a carboxylic acid.  
The carboxylic acid (5) can be subjected to decarboxylative cross-coupling conditions to close the centre 
ring and generate the desired 2,3-thienoisoquinoline system.  Using a decarboxylative cross-coupling 
rather than a C-H activation reaction would allow for selective coupling at the C2 position rather than a 
potential mixture of isomers derived from arylation at C2 and C4.  The C4-H was previously shown to be 
reactive under C-H activation conditions (Table 3).  The 2,3-thienoisoquinoline can then be 
functionalized at the C5 position through C-H activation or bromination. 
The previously synthesized key intermediate (2), was saponified under basic conditions to reveal the 
carboxylic acid (5).  The carboxylic acid was then subjected to palladium cross-coupling conditions 
without further purification to form the desired 2,3-thienoisoquinoline (6).  Initial conditions were 
derived from the decarboxylative cross-coupling reported by Forgione and co-workers.35  Fortunately, 
first attempts were successful generating the desired product in excellent yields.  Optimizations 
determined that the originally required additive (nBu4NCl) was not essential to the reaction, further 
improving the atom economy of the reaction. 
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Entry Ar X T (°C) t (min) Heating Method Yield (%) 
1 4-CH3C6H4 Br 170 8 microwave 99 
2 3-CH3C6H4 Br 170 8 microwave 76 
3 2-CH3C6H4 Br 170 8 microwave 84 
4 4-CH3OC6H4 Br 170 8 microwave 99 
5 4-FC6H4 Br 170 8 microwave 56 
6 4-NO2C6H4 Br 170 8 microwave 0 
7 2-thiophene Br 170 8 microwave 83 
8 4-CH3C6H4 Cl 170 8 microwave 0 
9 4-CH3C6H4 Br 100 960 (16 h) thermal 83 
10 4-CH3C6H4 Br 140 60 thermal 99 
11 3-CH3C6H4 Br 140 60 thermal 98 
12 2-CH3C6H4 Br 140 60 thermal 97 
Table 6 – Scope and optimizations of decarboxylative cross-coupling reaction 
Decarboxylative cross-coupling proved to be effective for a wide scope of sulfonamides.  Different 
sterically demanding sulfonamide aryl substituents were used (Table 6, entries 1-3) resulting in good to 
excellent yields.  Electron-donating substituents (Table 6, entry 4) were also well tolerated resulting in 
excellent yields.  However, electron-withdrawing substituents (Table 6, entry 5) was less well tolerated 
resulting in lower yields.  The strongly electron-withdrawing nitro substituent (Table 6, entry 6) was 
found to stop the reaction from occurring.  The potential for the nitro substituent to co-ordinate with 
palladium could potentially prevent the co-ordination of palladium with the carboxylate thus hindering 
activity.  Heteroaromatic substituents (Table 6, entry 7) were found to also be well tolerated giving 
excellent yields.  This further demonstrates the advantages of decarboxylative cross-coupling over C-H 
activation.  If a decarboxylative cross-coupling was not employed and a reactive hydrogen was present 
at C2, under C-H activation conditions, it is probable that a mix of regioisomers would be obtained for 
the intramolecular cross-coupling reaction.  Arylation at C2 would generate the desired 2,3-
thienoisoquinoline (6a) however, as previously demonstrated in Scheme 38, the C4 position of the 
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thiophene is also reactive under C-H activation conditions generating 3,4-thienoisoquinolines.  
Therefore, a mix of regioisomers is expected to occur when not employing a decarboxylative cross-
coupling. 
 
Scheme 43 – Regioselectivity issues when employing C-H activation 
Furthermore, with an additional thiophene substituent present on the sulfonamide, numerous reactive 
hydrogens are present increasing the potential for undesired intermolecular arylation.  Therefore, to 
obtain selective arylation and minimize the potential for undesired by-products, the selectivity of 
decarboxylative cross-coupling is required. 
Switching aryl bromides to the less reactive aryl chloride (Table 6, entry 8) also proved to stop the 
reaction under these reaction conditions.  Although using microwave as a heating method produced in 
general excellent results in a short reaction time, the limited size of the microwave reactor presented a 
challenge for larger scale reactions.  Thermal heating conditions would have to be optimized to allow for 
further development as a pharmaceutical agent. Therefore, thermal heating options were explored by 
reducing the temperature to 100 °C and heating for a longer period of time (Table 6, entry 9).  This 
proved to be effective, generating the desired product in 83% yield over a period of 16 h.  Furthermore, 
this demonstrated a low temperature decarboxylative cross-coupling that was previously not widely 
reported.  Although this procedure provided an excellent thermal alternative, the long reaction times 
were undesirable.  To circumvent the long reaction times, the temperature of the reaction was 
increased to augment reaction rates (Table 6, entry 10).  Heating the reaction at 140 °C for 1 h resulted 
in excellent yields in a short amount of time.  In summary, the initial conditions reported by Forgione 
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and co-workers proved to be effective on small scale reactions.  The reaction was further optimized to 
employ thermal heating conditions to facilitate larger scale reactions.  Furthermore, the decarboxylative 
cross-coupling was found to proceed at lower temperatures than previous examples. 
With the desired 2,3-thienoisoquinolines synthesized, efforts were focused on the functionalization of 
these compounds at the C5 position.  This functionalization would be important for structure activity 
relationship studies towards the development of these compounds as potential therapeutics.  To obtain 
similar substrates developed by Wyeth,1 2,3-thienoisoquinolines (6) were functionalized with aryl groups 
through C-H activation or brominated using NBS. 
 
Entry Ar R Yield (%) 
1 4-CH3C6H4 C6H5 78 
2 4-CH3C6H4 3-MeOC6H4 99 
3 4-CH3C6H4 4-MeOC6H4 99 
4 4-CH3C6H4 3-COOEtC6H4 87 
5 4-CH3C6H4 4-COOEtC6H4 87 
6 4-CH3C6H4 Br 60 
7 4-MeOC6H4 Br 59 
Table 7 – Functionalization of 2,3-thienoisoquinolines 
Firstly, the C5 position of the thienoisoquinoline was arylated through C-H activation (entries 1-5) 
resulting in good to excellent yields.  The reaction was well tolerant of different electronically 
demanding aryl bromides including electron rich (Table 7, entries 2-3) and electron poor (Table 7, 
entries 4-5).  However, electronically neutral species (Table 7, entry 1) proved to be more difficult 
resulting in slightly lower yields.  Furthermore, the C5 position could be brominated using NBS resulting 
in the brominated inhibitors that were previously reported.  Bromination of 2,3-thienoisoquinoline was 
achieved in good yields (Table 7, entries 6, 7) with two different sulfonamide derivatives. 
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In summary, a five-step synthesis of functionalized 2,3-thienoisoquinolines was achieved employing a 
decarboxylative cross-coupling for selective ring closure followed by a functionalization using C-H 
activation or bromination.  This synthesis improves upon a previous synthesis reported by Wyeth by 3 
steps while maintaining late stage diversification. 
Although this synthesis improves upon previous routes towards these biologically active compounds, 
there are possibilities for further improvements by further reducing the synthetic steps towards these 
inhibitors.  The final three steps of the previous synthesis involve a saponification followed by a 
palladium-catalyzed decarboxylative cross-coupling then functionalization through a second palladium-
catalyzed arylation.  With two sequential palladium-catalyzed cross-coupling reactions, a possibility 
exists to combine the two arylations into a single step.  This would effectively reduce the step count 
from five to four and eliminate a purification step increasing the ease of scalability and reducing the 
amount of waste produced. 
Carboxylic acid (5a) was subjected to palladium catalysis conditions with an external aryl bromide in 
efforts to conduct a decarboxylative cross-coupling and C-H activation in a single step.  Initial conditions 
were derived from a combination of previously used decarboxylative cross-coupling35,36 and C-H 
activation reactions.24 
 
Scheme 44 – Initial attempts towards the development of a one pot decarboxylative cross-coupling C-H activation reaction 
Initial conditions proved to be effective generating the desired product in a 59% yield.  However, upon 
analysis of the unpurified mixture of products, two major by-products were also produced.  
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Protodecarboxylation of the starting carboxylic acid resulted in thiophene (92a) which did not react 
further under the reaction conditions.  The second undesired product produced was the 
unfunctionalized 2,3-thienoisoquinoline (6b) which was not fully converted to the desired product under 
the reaction conditions.  Therefore, in attempts to improve the yield of the functionalized 2,3-
thienoisoquinoline, minimize the formation of the protodecarboxylation (92a) side product and to fully 
convert the unfunctionalized 2,3-thienoisoquinoline intermediate (6b), different palladium sources were 
screened. 
 
 Yield (%)
a
 
Entry Pd Source Protodecarboxylation Intermediate Product 
1 PdCl2 1 15 59 
2 Pd(acac)2 2 51 14 
3 Petey 1 51 24 
4 Pd(OAc)2 8 36 26 
5 Pd(dba)2 28 14 0 
6 PdI2 5 29 25 
7 Pd(OAc)2
b
 8 47 28 
a
 Yields normalized to an isolated yield of 59% obtained for entry 1 
b
 10 mol% palladium was used 
Table 8 – Optimization of palladium sources 
Initial attempts using palladium chloride as catalyst generated the desired product in an isolated yield of 
59% (Table 8, entry 1).  However, 16% of the mass balance was attributed to the formation of 
protodecarboxylation and unfunctionalized intermediate products.  Therefore, the yield could be 
potentially increased by minimizing protodecarboxylation and fully converting the unfunctionalized 
intermediate.  To further improve the yield of the reaction, a survey of different palladium sources was 
conducted and the results were analyzed by GC-MS normalizing yields to an isolated yield of 59% 
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obtained for entry 1.  Switching palladium sources from palladium chloride to Pd(acac)2 (Table 8, entry 
2) resulted in a decrease of desired product formation, however an increase of the amount of 
intermediate formation occurred.  This suggests that Pd(acac)2 serves as a suitable palladium source for 
the initial decarboxylative cross-coupling reaction however does not easily facilitate C-H activation.  
Changing the palladium source to Petey or palladium acetate (Table 8, entries 3, 4) gave similar results 
with the majority of the mass balance in the intermediate product.  The more stable Pd(dba)2 (Table 8, 
entry 5) was found to be the least effective palladium source for the desired transformation resulting in 
the majority of the mass balance in the protodecarboxylation side product.  Changing the counter ion 
from chloride to iodide also proved to be detrimental to the reaction; this resulted in an equal mix of 
intermediate and product (Table 8, entry 6).  Finally, increasing palladium acetate loading did not have a 
major impact on the reaction giving similar results to 5 mol% loading (Table 8, entry 4).  In summary, 
initial use of palladium chloride proved to be the most effective source of catalyst.  With a palladium 
source optimized, different ligands were surveyed to further optimize product formation. 
 
 Yield (%)
a
 
Entry Ligand Protodecarboxylation Intermediate Product 
1 PCy3HBF4 1 15 59 
2 dppf 5 71 7 
3 P
t
Bu3HBF4 1 28 28 
4 Mor-Dalphos 7 35 4 
5 Johnphos 2 36 19 
6 Davephos 18 26 9 
7 PPh3 10 33 8 
a
 Yields normalized to an isolated yield of 59% obtained for entry 1 
Table 9 – Optimization of ligand 
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Initial conditions (Table 9, entry 1) employed the use of tricyclohexylphosphine as a ligand and resulted 
in a yield of 59%.  Using the bidentate ligand dppf (Table 9, entry 2) proved to be very effective in the 
initial decarboxylative cross-coupling step generating a substantial amount of the intermediate.  
However, dppf was found to be unsuitable for C-H activation generating, minimal amounts of product.  
Since bi-dentate ligands prove to be ineffective for the desired reaction, various monodentate 
phosphine ligands of different steric bulk were explored.  Increasing steric bulk with a variety of ligands 
(Table 9, entries 3-7) did not facilitate more product formation in all cases, approximately a third of the 
mass balance resulted in intermediate formation with minimal product.  In summary, the initial ligand, 
tricyclohexylphosphine, proved to be most effective for the transformation.  With an optimized catalyst 
and ligand system established, the temperature, reaction time and equivalents of aryl bromide were 
optimized. 
 
Entry T (°C) t (h) Equiv. Ar-Br Yield (%) 
1 80 16 1.0 0 
2 100 16 1.0 59 
3 120 6 1.0 58 
4 100 16 1.2 --
a
 
5 100 16 1.5 --
a
 
6 100 16 2.0 --
a
 
a
 Unable to isolate the desired product in high purity by column chromatography. 
Table 10 – Optimization of time, temperature and equivalents of Ar-Br 
Initial conditions heating at 100 °C for 16 h with one equivalent of aryl bromide (entry 2) resulted in an 
isolated yield of 59%.  Decreasing the temperature to 80 °C while keeping reaction time constant proved 
to be detrimental, resulting in minimal formation of product.  However, increasing the temperature to 
120 °C (entry 3) allowed a similar amount of product formation to occur in a reduced time of 6 h.  
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Increasing the equivalents of Ar-Br (entries 4-6) was found to increase the yield of desired product as 
determined by NMR.  However the increase of Ar-Br also increased the formation of inseparable 
impurities which could not be identified and lead to the contamination of the desired product.  Due to 
difficulties in purification associated with increasing the equivalents of Ar-Br, the addition of one 
equivalent of Ar-Br was determined to be optimal.  As such, to reduce reaction time and increase the 
efficiency of optimization studies, conditions employed in entry 3 were used to explore the substrate 
scope of different aryl bromides. 
 
Scheme 45 – General scheme of aryl bromide scope 
Unfortunately, similar to the increase of equivalents used of aryl bromide, different substrates resulted 
in inseparable mixtures of the intermediate 2,3-thienoisoquinoline, the desired product and other 
unidentifiable impurities.  As such, conditions were re-optimized with bromobenzene as a substrate 
rather than 3-bromoanisole.  Bromobenzene under the original optimized conditions gave an 
inseparable mixture of products.  The goal for secondary optimizations was to both minimize 
protodecarboxylation side product and to minimize unreacted intermediate.  This would allow for an 
easier separation of the mixture of final products.  As PdCl2 was previously found to be the optimal 
palladium source, a survey of ligands was conducted as a first step. 
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 Yield (%)
a
 
Entry Ligand Protodecarboxylation Intermediate Product 
1 PCy3HBF4 19 9 50 
2 dppf 19 29 30 
3 P
t
Bu3HBF4 2 11 66 
4 Mor-Dalphos 71 4 4 
5 Johnphos 36 20 22 
6 Davephos 25 9 44 
7 PPh3 30 16 32 
8 P(OC(CF3)2)3 30 19 30 
a
 Yields normalized to an isolated yield of 66% obtained for entry 3 
Table 11 – Second ligand optimization 
With the originally optimized conditions (Table 11, entry 1) using bromobenzene as an arylating agent, 
19% of the mass balance was attributed to the product formed through protodecarboxylation which 
could not be transformed into the desired product.  Another 9% of the mass balance was found to be 
unfunctionalized intermediate which could potentially be fully converted to further increase the yield of 
the desired product. Using the bi-dentate ligand dppf, (Table 11, entry 2) again proved to be detrimental 
to the reaction, lowering the yield of the desired product while increasing the yield of the intermediate.  
This again demonstrated that dppf is a suitable ligand for decarboxylative cross-coupling but does not 
facilitate a subsequent C-H activation and that the results were not dependent on the aryl bromide 
used.  A bulkier monodentate phosphine ligand, tri-tert-butylphosphine (Table 11, entry 3), was found to 
be effective, decreasing the amount of protodecarboxylation side product and decreasing the residual 
amount of intermediate while maintaining good yields for the desired product.  With 11% of the mass 
balance as the unfunctionalized 2,3-thienoisoquinoline there was potential to further increase the yield 
of the desired product.  Drastically increasing steric bulk of the ligand using the adamant-based Mor-
Dalphos ligand (Table 11, entry 4) proved to be extremely detrimental to both cross-coupling reactions.  
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However, this catalyst ligand system was found to be effective in facilitating protodecarboxylation.  
Buchwald-type ligands (Table 11, entries 5, 6) were also attempted resulting in a mixture of all three 
products in similar equivalents.  Similarly, different phosphine ligands (Table 11, entries 7, 8) also gave 
mixtures of all three products.  In summary, although the original ligand choice of 
tricyclohexylphosphine gave reasonable yields, the amount of protodecarboxylation side product and 
unfunctionalized intermediate produced decreased yields of the desired product and complicated final 
purification.  As such, the more sterically hindered tri-tert-butylphosphine ligand was found to be the 
optimal ligand for this system generating the best ratio of product, intermediate and 
protodecarboxylation.  With an optimized palladium/ligand system, the base that was previously not 
optimized was examined. 
 
 Yield (%)
a
 
Entry Base Protodecarboxylation Intermediate Product 
1 K2CO3 (3.0 equiv.) 2 11 66 
2 Na2CO3 (3.0 equiv.) 2 10 18 
3 Cs2CO3 (3.0 equiv.) 1 2 80 
4 NaOH (3.0 equiv.) 0 0 0 
5 Cs2CO3 (2.0 equiv.) 1 5 37 
6 Cs2CO3 (1.5 equiv.) 5 11 21 
7 Cs2CO3 (1.0 equiv.) 1 6 7 
8 Cs2CO3 (0.5 equiv.) 2 17 0 
9 Et3N (2.0 equiv.) 4 56 0 
a
 Yields normalized to an isolated yield of 80% obtained for entry 3 
Table 12 – Optimization of bases 
Different carbonate bases were explored to determine the effect of counter-ions on the system.  
Switching the original base K2CO3 to Na2CO3 (Table 12, entry 2), was found to severely hinder the 
reaction in all aspects, decreasing the yield of both cross-coupling reactions and decreasing the amount 
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of protodecarboxylation product formed.  Increasing the size of the counter-ion using Cs2CO3 (Table 12, 
entry 3) as the base proved to be beneficial to the reaction.  Using cesium carbonate as a base resulted 
in the formation of a similar amount of protodecarboxylation product.  However, it was found that 
Cs2CO3 facilitated C-H activation converting the majority of the unfunctionalized intermediate to the 
desired product.  As such, Cs2CO3, appears to be effective in C-H activation as high amounts of product 
and minimal amounts of intermediate is observed.  A different inorganic base, sodium hydroxide (Table 
12, entry 4), was attempted however no desired reactions was observed.  An attempt to decrease the 
equivalents of Cs2CO3, required for the reaction (Table 12, entries 5-8) proved to be detrimental to the 
reaction, limiting the amount of cross-coupling product observed.  Finally, an organic base (Et3N, Table 
12, entry 9) was attempted.  This base however was found to facilitate only the first step of 
decarboxylative cross-coupling and did not facilitate the subsequent C-H activation.  In summary, cesium 
carbonate proved to be the most effective base when used in 3 equivalents.  Lowering the equivalents 
of the base or employing smaller counter-ions proved to be detrimental to final product formation.  
With the information gathered during optimization studies, a mechanism can be proposed based on 
previously known mechanisms for decarboxylative cross-coupling and C-H activation. 
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Scheme 46 – Proposed mechanism for a one-pot decarboxylative cross-coupling C-H activation reaction 
Similar to the proposed mechanism for double C-H activation (Scheme 39) this one-pot reaction can be 
seen as two catalytic cycles occurring in tandem both mediated by a palladium (0) catalyst.  The 
carboxylic acid can be subjected to two pathways; firstly protodecarboxylation resulting in an unwanted 
side product (92) or the palladium (0) catalyst can undergo an oxidative insertion into the aryl bromide 
(5) bond.  The oxidative addition would allow for the palladium to be in close proximity to the 
carboxylate facilitating co-ordination and anion exchange.  Electrons on the heteroatom then delocalize 
and undergo a nucleophilic attack onto the electrophilic palladium species metallating at the C2 position 
(94).  The carboxylate then undergoes decarboxylation to restore aromaticity.  The seven membered 
palladacycle (95) then undergoes reductive elimination forming the 2,3-thienoisoquinoline intermediate 
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(6) and regenerating the active palladium (0) catalyst (21).  The catalyst then undergoes oxidative 
addition into an external aryl bromide (22) bond which upon anion exchange with pivalate can undergo 
a concerted metallation deprotonation sequence with the C5 position of the newly formed 2,3-
thienoisoquinoline (6).  The resulting palladated species (93) can then undergo a reductive elimination 
forming the carbon-carbon bond and regenerating the active palladium (0) catalyst (21). 
With extensive optimizations and a proposed mechanism complete, future directions of this project are 
aimed towards the exploration of the scope of this one-pot process and biological testing of these active 
compounds for potential therapeutic use. 
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CHAPTER 3 – EXPERIMENTAL 
General Considerations: All glassware was flame dried under argon prior to reaction set-up unless 
otherwise stated. Solids were weighed open to air and added to a septum sealed round bottle flask that 
was then purged with argon gas. Liquids were transferred using plastic or glass syringes and stainless 
steel syringe needles to maintain an inert atmosphere. Flash chromatography was carried out using 40-
63 μm silica gel (Silicycle). 
Materials: All solvents were purchased as ACS grade from Fisher Scientific or JT Baker and were stored 
under an inert atmosphere with activated 3Å molecular sieves.  Molecular sieves were activated by 
heating at 150 °C for 16 h under high vacuum.  Distilled water was obtained from an in-house water 
distillery. All other reagents and chemicals were purchased from Sigma-Aldrich or Alfa Aesar and used 
without further purification. 
Instrumentation: 1H (500MHz) and 13C (125MHz) NMR spectra were recorded in CDCl3 using a Varian 
Inova 500MHz spectrometer. Spectra were referenced to the residual solvent signal or internal TMS 
signal. Spectral features are tabulated in the following order: chemical shift (δ, ppm); multiplicity (s-
singlet, d-doublet, t-triplet, q-quartet, dd-doublet of doublets, m-multiplet); coupling constants (J, Hz); 
number of protons; assignment based on chemical shifts of proton signals. High resolution mass spectra 
(HRMS) were obtained using a LC-Tof ESI positive mode mass spectrometer. Infrared (IR) spectra were 
obtained on a Nicolet 6700 FT-IR spectrometer as % transmittance as neat thin films loaded with CDCl3 
and allowed to dry on a sodium chloride window. Spectral features are tabulated by wavenumber (cm-1). 
Microwave reactions were carried out using Biotage initiator 2.3 build 6250 system with a 400 watt 
magnetron. 
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General procedure for the synthesis of sulfonamides (Procedure 1) 
 
A procedure by Tondi and co-workers was used with modifications.45 Pyridine (0.8 M) was added to aryl 
sulfonyl chloride (1.5 equiv.) and 3-amino-thiophene-2-methyl-carboxylate (1 equiv.) and heated to 50 
ᵒC for 1 hour. After 1 hour the resulting mixture was cooled to 23 ᵒC then was diluted in EtOAc and 
washed with distilled water. The aqueous phase was extracted with EtOAc and the combined organics 
were washed 5 times with distilled water. The organics were then dried over anhydrous sodium sulfate, 
filtered over a cotton plug and the solvent was removed under reduced pressure. The resulting mixture 
was recrystalized using EtOAc and hexanes. 
 
Synthesis of NW-060 (78a) 
 
NW-060 was prepared following the general procedure for the preparation of sulfonamides (procedure 
1) on a 31.8 mmol (5.0 g) scale. Yield 83 % colourless crystalline solid. (m.p. 149-150 ᵒC) 1H NMR (CDCl3, 
500 MHz) δ ppm 7.74 (d, J = 8.0 Hz, 2H), 7.39 (s, 2H), 7.25 (d, J = 80 Hz, 2H), 3.83 (s, 3H), 2.38 (s, 3H). 13C 
NMR (CDCl3, 125 MHz) δ ppm 164.2, 144.1, 143.4, 136.2 (2C), 131.9, 129.7 (2C), 126.8, 120.3, 110.4, 
51.9, 21.4. (IR (NaCl): 3201, 3118, 2956, 1671, 1597, 1546, 1400, 1163, 1032, 876. HRMS (EI): Exact mass 
calculated for C13H13NO4S2 [M + H]
+: 312.03588 found 312.03625. 
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Synthesis of NW-151 (78b) 
 
NW-151 was prepared following the general procedure for the preparation of sulfonamides (procedure 
1) on a 6.36 mmol (1.0 g) scale. Yield: 83 % beige solid. (m.p. 96-97 ᵒC) 1H NMR (CDCl3, 500 MHz) δ ppm 
7.68-7.65 (m, 2H), 7.39 (s, 2H), 7.35-7.34 (m, 2H), 3.84 (s, 3H), 2.38 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 
ppm 164.2, 143.4, 139.4, 139.1, 134.0, 131.9, 128.9, 127.2, 124.0, 120.4, 110.5, 52.0, 21.2. (IR (NaCl): 
3241, 2954, 1676, 1548, 1448, 1384, 1276, 1244, 1162, 1096, 1035. HRMS (EI): Exact mass calculated for 
C13H13NO4S2 [M + H]
+: 312.03588 found 312.03571. 
 
Synthesis of NW-150 (78c) 
 
NW-150 was prepared following the general procedure for the preparation of sulfonamides (procedure 
1) on a 6.36 mmol (1.0 g) scale. Yield: 68 % pink solid. (m.p. 127-128 ᵒC) 1H NMR (CDCl3, 500 MHz) δ ppm 
8.02 (d, J = 8.0 Hz, 1H), 7.36 (t, J = 8.0 Hz, 1H), 7.34-7.33 (m, 1H), 7.31-7.25 (m, 3H), 3.87 (s, 3H), 2.69 (s, 
3H). 13C NMR (CDCl3, 125 MHz) δ ppm 164.3, 143.3, 137.3, 133.3, 132.7, 132.0, 129.5, 126.5, 126.1, 
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119.7, 109.5, 52.0, 20.0. (IR (NaCl): 3234, 3131, 2952, 1679, 1547, 1404, 1375, 1243, 1171, 1033. HRMS 
(EI): Exact mass calculated for C13H13NO4S2 [M + H]
+: 312.03588 found 312.03457. 
 
Synthesis of NW-2-010 (78d) 
 
NW-2-010 was prepared following the general procedure for the preparation of sulfonamides 
(procedure 1) on a 6.36 mmol (1.0 g) scale. Yield: 81 % beige solid. (m.p. 99-100 ᵒC) 1H NMR (CDCl3, 500 
MHz) δ ppm 7.39 (s, 2H), 7.36 (m, 2H), 6.91-6.88 (m, 2H) 3.81 (s, 3H), 3.80 (s, 3H). 13C NMR (CDCl3, 125 
MHz) δ ppm 164.2, 163.2, 143.6 (2C), 131.8 (2C), 130.7, 129.1, 120.5, 114.3, 110.5, 55.5, 52.0. (IR (NaCl): 
3244, 2361, 2338, 1675, 1577, 1383, 1243, 1161, 1093, 1032. HRMS (EI): Exact mass calculated for 
C13H13NO5S2 [M + H]
+: 328.03079 found 328.03105. 
 
Synthesis of NW-149 (78e) 
 
NW-149 was prepared following the general procedure for the preparation of sulfonamides (procedure 
1) on a 6.36 mmol (1.0 g) scale. Yield: 68 % pink solid. (m.p. 137-138 ᵒC) 1H NMR (CDCl3, 500 MHz) δ ppm 
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8.30 (d, J = 9.0 Hz, 2H), 8.05-8.03 (m, 2H), 7.44 (m, 2H), 3.84 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 
164.3, 150.4, 144.9 (2C). 142.4, 132.4 (2C), 128.3, 124.4, 120.5, 111.8, 52.3. (IR (NaCl): 3192, 3106, 2955, 
1678, 1530, 1403, 1351, 1243, 1168, 1089. HRMS (EI): Exact mass calculated for C12H10N2O6S2 [M + H]
+: 
343.0053 found 343.0055. 
 
Synthesis of NW-2-053 (78f) 
 
NW-2-053 was prepared following the general procedure for the preparation of sulfonamides 
(procedure 1) on a 6.36 mmol (1.0 g) scale. Yield: 65 % beige solid. (m.p. 88-89 ᵒC) 1H NMR (CDCl3, 500 
MHz) δ ppm 9.60 (br s, 1H), 7.87-7.84 (m, 2H), 7.42-7.36 (m, 2H), 7.14-7.09 (m, 2H) 3.82 (s, 3H). 13C NMR 
(CDCl3, 125 MHz) δ ppm 166.3, 164.2, 143.1 (2C), 135.3 (2C), 132.0, 129.7, 120.5, 116.3, 111.1, 52.1. (IR 
(NaCl):3238, 3106, 2955, 1680, 1593, 1545, 1494, 1449, 1404, 1277, 1240, 1170, 1157, 1090, 1034, 950. 
HRMS (EI): Exact mass calculated for C12H10FNO4S2 [M + H]
+: 316.0108 found 316.01132. 
 
Synthesis of NW-152 (78g) 
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NW-152 was prepared following the general procedure for the preparation of sulfonamides (procedure 
1) on a 6.36 mmol (1.0 g) scale. Yield: 69 % beige solid. (m.p. 115-116 ᵒC) 1H NMR (CDCl3, 500 MHz) δ 
ppm 7.62-7.61 (m, 1H), 7.56-7.54 (m, 1H), 7.46-7.44 (m, 2H), 7.04-7.02 (m, 1H) 3.84 (s, 3H). 13C NMR 
(CDCl3, 125 MHz) δ ppm 164.2, 143.0, 139.9, 132.7, 132.6, 131.9, 127.4, 120.7, 111.2, 52.1. (IR (NaCl): 
3193, 3118, 1668, 1551, 1451, 1384, 1256, 1156, 1037. HRMS (EI): Exact mass calculated for C10H9NO4S3 
[M + H]+: 303.97655 found 303.97687. 
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General procedure for benzylation (Procedure 2) 
 
A procedure by Fawzi and co-workers was used with modifications.47  Benzyl bromides and benzyl 
chlorides (1.2 equiv.) were added to a mixture of sulfonamide (1 equiv.) and K2CO3 (2 equiv.) in DMF (0.3 
M) then heated to 50 ᵒC or 80 °C. The resulting mixture was cooled to 23 °C then diluted with EtOAc and 
was brought to pH = 2 with 1 M HCl(aq.). The phases were then separated and the aqueous phase was 
extracted with EtOAc. The combined organics were washed three times with water then were dried over 
anhydrous sodium sulfate, filtered over a cotton plug and the solvent was removed under reduced 
pressure. The resulting mixture was recrystalized with EtOAc and hexanes. 
 
Synthesis of NW-104 (2a) 
 
NW-104 was prepared following the general procedure for benzylation of sulfonamides (procedure 2) 
on a 9.64 mmol (3.0 g) scale. Yield: 92 % beige solid. (m.p. 118-119 ᵒC) 1H NMR (CDCl3, 500 MHz) δ ppm 
7.67 (dd, Js = 2,0 Hz, Jl = 8,0 Hz, 1H), 7.58 (d, J = 8.0 Hz, 2H), 7.41 (dd, Js = 2.0 Hz, Jl = 8.0 Hz, 1H), 7.33 (d, 
J = 5.0 Hz 1H), 7.29-7.26 (m, 3H), 7.08 (m, 1H), 6.93 (d, J = 5.0 Hz, 1H), 5.02 (s, 2H), 3.60 (s, 3H), 2.43 (s, 
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3H). 13C NMR (CDCl3, 125 MHz) δ ppm 160.5, 143.4 (2C), 140.4, 136.3 (2C), 135.8, 132.6 (2C), 131.2, 
130.8, 129.1, 129.0, 128.5, 127.6, 127.5, 123.6, 54.6, 51.9, 21.5. (IR (NaCl): 3110, 2950, 1721, 1598, 
1522, 1438, 1352, 1264, 1164, 1091. HRMS (EI): Exact mass calculated for C20H18BrNO4S2 [M + H]
+: 
479.99334 found 479.99419. 
 
Synthesis of NW-160 (2b) 
 
NW-160 was prepared following the general procedure for benzylation of sulfonamides (procedure 2) 
on a 0.64 mmol (0.2 g) scale. Yield: 83 % colourless needles. (m.p. 123-124 ᵒC) 1H NMR (CDCl3, 500 MHz) 
δ ppm 7.67 (dd, Js = 1.5 Hz, Jl = 8.0 Hz, 1H), 7.53-7.49 (m, 2H), 7.41 (dd, Js = 1.5 Hz, J = 8.0 Hz, 1H), 7.37-
7.33 (m, 3H), 7.28 (td, Js = 1.5 Hz, Jl = 8.0 Hz, 1H), 7.08 (td, Js = 1.5 Hz, Jl = 8.0 Hz, 1H), 6.92 (d, J = 5.5 Hz, 
1H), 5.03 (s, 2H), 3.59 (s, 3H), 2.39 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 160.5, 140.3, 139.1, 138.8, 
135.8, 133.4, 132.6, 131.3, 130.9, 129.1, 129.0, 128.6, 127.9, 127.5, 124.7, 123.6, 104.9, 54.6, 51.8, 21.2. 
(IR (NaCl): 2950, 1721, 1438, 1352, 1158, 1086. HRMS (EI): Exact mass calculated for C20H18BrNO4S2 [M + 
H]+: 479.99334 found 479.99152. 
 
Synthesis of NW-154 (2c) 
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NW-154 was prepared following the general procedure for benzylation of sulfonamides (procedure 2) 
on a 0.64 mmol (0.2 g) scale. Yield: 95 % colourless needles. (m.p. 108-109 ᵒC) 1H NMR (CDCl3, 500 MHz) 
δ ppm 7.76 (dd, Js = 1.0 Hz, Jl = 8.0 Hz, 1H), 7.68 (dd, Js = 1.0 Hz, Jl = 8.0 Hz, 1H), 7.43-7.39 (m, 2H), 7.30-
7.22 (m, 4H), 7.08 (td, Js = 1.5 Hz, Jl = 8.0 Hz, 1H), 6.96 (d, J = 5.5 Hz, 1H), 5.16 (s, 2H), 3.58 (s, 3H), 2.48 
(s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 160.5, 140.1, 138.2 (2C), 137.7, 136.0, 132.6, 132.5, 131.9, 
131.1, 130.2, 129.2, 128.8, 128.6, 127.6, 125.9, 123.9, 54.6, 51.9, 21.1. (IR (NaCl): 3062, 2950, 1719, 
1522, 1438, 1396, 1347, 1265, 1231, 1164, 1061. HRMS (EI): Exact mass calculated for C20H18BrNO4S2 [M 
+ H]+: 479.99334 found 479.99446. 
 
Synthesis of NW-2-067 (2d) 
 
NW-2-067 was prepared following the general procedure for benzylation of sulfonamides (procedure 2) 
on a 2.44 mmol (0.8 g) scale. Yield: 98 % colourless crystal. (m.p. 125-126 ᵒC) 1H NMR (CDCl3, 500 MHz) δ 
ppm 7.67-7.62 (m, 3H), 7.40 (dd, Js = 2.0 Hz, Jl = 8.0 Hz, 1H), 7.32 (d, J = 5.5 Hz, 1H), 7.26 (td, Js = 1.5 Hz, 
Jl = 8.0 Hz, 1H), 7.06 (td, Js = 1.5 Hz, Jl = 8.0 Hz, 1H), 6.94-6.91 (m, 3H), 5.01 (s, 2H), 3.85 (s, 3H), 3.63 (s, 
3H). 13C NMR (CDCl3, 125 MHz) δ ppm 163.0, 160.5, 140.5 (2C), 135.8 (2C), 132.5, 131.1, 130.8 (2C), 
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129.7, 129.1, 129.0, 128.4, 127.5, 123.5, 113.8, 55.5, 54.5, 51.9. (IR (NaCl): 3109, 2949, 2840, 2362, 
1720, 1596, 1498, 1438, 1351, 1260, 1159, 1092, 1023. HRMS (EI): Exact mass calculated for 
C20H18BrNO5S2 [M + H]
+: 495.98825 found 495.98608. 
 
Synthesis of NW-153 (2e) 
 
NW-153 was prepared following the general procedure for benzylation of sulfonamides (procedure 2) 
on a 0.58 mmol (0.2 g) scale. Yield: 98 % colourless crystal. (m.p. 188-189 ᵒC) 1H NMR (CDCl3, 500 MHz) δ 
ppm 8.30 (d, J = 9.0 Hz, 2H), 7.88 (d, J = 9.0 Hz, 2H), 7.57 (dd, Js = 1.5 Hz, Jl = 8.0 Hz, 1H), 7.44 (dd, Js = 
1.5 Hz, Jl = 8.0 Hz, 1H), 7.36 (d, J = 5.0 Hz, 1H), 7.28 (td, Js = 1.0 Hz, Jl = 8.0 Hz, 1H), 7.10 (td, Js = 1.0 Hz, Jl 
= 8.0 Hz, 1H), 6.95 (d, J = 5.0 Hz, 1H), 5.08 (s, 2H), 3.58 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 160.2, 
150.1, 144.9 (2C), 139.7, 135.0 (2C), 132.8, 131.7 (2C), 131.0, 129.5 (2C), 128.8, 127.8, 127.6, 123.9, 
54.6, 52.0. (IR (NaCl): 3107, 1711, 1531, 1437, 1350, 1169, 1090. HRMS (EI): Exact mass calculated for 
C19H15BrN2O6S2 [M + H]
+: 510.96277 found 510.96379. 
 
Synthesis of NW-2-066 (2f) 
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NW-2-066 was prepared following the general procedure for benzylation of sulfonamides (procedure 2) 
on a 1.60 mmol (0.5 g) scale. Yield: 94 % colourless crystal. (m.p. 162-163 ᵒC) 1H NMR (CDCl3, 500 MHz) δ 
ppm 7.74-7.70 (m, 2H), 7.62 (dd, Js = 1.5 Hz, Jl = 8.0 Hz, 1H), 7.41 (dd, Js = 1.5 Hz, Jl = 8.0 Hz, 1H), 7.33 (d, 
J = 5.5 Hz, 1H), 7.27 (td, Js = 1.5 Hz, Jl = 8.0 Hz, 1H), 7.16-7.11 (m, 2H), 7.07 (td, Js = 1.5 Hz, Jl = 8.0 Hz, 
1H), 6.94 (d, J = 5.5 Hz, 1H), 5.04 (s, 2H), 3.63 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 166.2, 164.1, 
160.3, 140.2 (2C), 135.6, 135.3, 132.6, 131.4 (2C), 130.8, 130.3, 129.2, 128.2, 127.5, 123.7, 115.9, 54.6, 
51.9. (IR (NaCl): 3237, 3106, 2955, 1678, 1593, 1548, 1494, 1448, 1388, 1277, 1243, 1172, 1090, 1035. 
HRMS (EI): Exact mass calculated for C19H15BrFNO4S2 [M + H]
+: 483.96827 found 483.96693. 
 
Synthesis of NW-161 (2g) 
 
NW-161 was prepared following the general procedure for benzylation of sulfonamides (procedure 2) 
on a 0.66 mmol (0.2 g) scale. Yield: 91 % colourless needles. (m.p. 125-126 ᵒC) 1H NMR (CDCl3, 500 MHz) 
δ ppm 7.63 (dd, Js = 1.5 Hz, Jl = 8.0 Hz, 1H), 7.60 (d, J = 5.5 Hz, 1H), 7.47 (dd, Js = 1.5 Hz, Jl = 4.0 Hz, 1H), 
7.42 (dd, Js = 1.5 Hz, Jl = 8.0 Hz, 1H), 7.34 (d, J = 5.5 Hz, 1H), 7.27 (td, Js = 1.5 Hz, Jl = 8.0 Hz, 1H), 7.10-
7.06 (m, 2H), 6.92 (d, J = 5.5 Hz, 1H), 5.06 (s, 2H), 3.68 (s, 3H) 13C NMR (CDCl3, 125 MHz) δ ppm 160.6, 
139.9, 139.7, 135.5, 132.6, 132.5, 132.2, 131.2, 130.9, 129.3 129.2, 128.7, 127.5, 127.3, 123.7, 54.7, 
52.1. (IR (NaCl): 3108, 2950, 2362, 2337, 1719, 1522, 1437, 1357, 1263, 1227, 1159, 1091, 1019. HRMS 
(EI): Exact mass calculated for C17H14BrNO4S3 [M + H]
+: 471.93411 found 471.93194. 
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Synthesis of NW-171 (2h) 
 
NW-171 was prepared following the general procedure for benzylation of sulfonamides (procedure 2) 
on a 2.41 mmol (0.75 g) scale. Yield: 88 % colourless powder. (m.p. 110-111 ᵒC) 1H NMR (CDCl3, 500 
MHz) δ ppm 7.63-7.58 (m, 3H), 7.31 (d, J = 5.5 Hz, 1H), 7.26-7.25 (m, 2H), 7.23-7.19 (m, 2H), 7.16-7.13 
(m, 1H), 6.91 (d, J = 5.5 Hz, 1H), 5.02 (s, 2H), 3.60 (s, 3H), 2.42 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 
160.5, 143.4 (2C), 140.4 (2C), 136.3, 134.1, 133.6, 131.1 (2C), 130.8, 129.3, 129.2, 129.0, 128.9, 128.5, 
127.6, 126.8, 52.1, 21.5. (IR (NaCl): 3110, 2951, 1721, 1522, 1438, 1353, 1165, 1092, 1030, 924, 814. 
HRMS (EI): Exact mass calculated for C20H18ClNO4S2 [M + H]
+: 436.04385 found 436.04186. 
 
Synthesis of NW-131 (2i) 
 
NW-131 was prepared following the general procedure for benzylation of sulfonamides (procedure 2) 
on a 0.94 mmol (0.3 g) scale. Yield: 99 % colourless powder. (m.p. 113-114 ᵒC) 1H NMR (CDCl3, 500 MHz) 
δ ppm 7.60 (d, J = 8.0 Hz, 2H), 7.29-7.25 (m, 3H), 7.15-7.06 (m, 2H), 6.86-6.81 (m, 2H), 5.09 (s, 2H), 3.57 
(s, 3H), 2.42 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 163.1, 161.1, 160.6, 143.3 (2C), 139.9, 136.5, 
136.3, 131.4, 130.0, 129.5, 129.2, 128.7, 127.7, 125.3, 122.1, 114.0, 51.8, 45.6, 21.5. (IR (NaCl): 3110, 
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2951, 1723, 1506, 1456, 1437, 1358, 1162, 1091. HRMS (EI): Exact mass calculated for C20H17ClFNO4S2 [M 
+ H]+: 454.03443 found 454.03288. 
 
Synthesis of NW-130 (2j) 
 
NW-130 was prepared following the general procedure for benzylation of sulfonamides (procedure 2) 
on a 0.96 mmol (0.3 g) scale. Yield: 83.1 % colourless crystal. (m.p. 175-176 ᵒC) 1H NMR (CDCl3, 500 MHz) 
δ ppm 7.60 (d, J = 8.5 Hz, 2H), 7.26-7.24 (m, 3H), 7.18 (s, 1H), 7.16 (s, 1H), 7.08-7.05 (m, 1H), 6.80 (d, J = 
5.5 Hz, 1H), 5.25 (s, 2H), 3.56 (s, 3H), 2.42 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 160.5, 143.2 (2C), 
139.4 (2C), 137.0, 136.5, 131.5, 131.3, 130.2 (2C), 129.6, 129.1, 128.6, 128.3, 127.8 (2C), 51.7, 49.2, 21.4. 
(IR (NaCl): 2950, 1723, 1703, 1437, 1355, 1164, 1093, 928, 777, 671, 562, 545. HRMS (EI): Exact mass 
calculated for C20H17Cl2NO4S2 [M + H]
+: 470.00488 found 470.00309. 
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General procedure for double C-H activation (Procedure 3) 
 
Procedure adapted from a method reported by Fagnou and co-workers.24 Aryl bromide (1 equiv.) was 
added to a solution of the benzyl sulfonamide (1 equiv.), Pd(OAc)2 (0.05 equiv.), PCy3·HBF4 (0.1 equiv.), 
pivalic acid (0.3 equiv), K2CO3 (1.5 equiv.) in DMA (0.1 M). The resulting mixture was heated to 100 ᵒC for 
16 h, was cooled to 23 °C and filtered over a packed pad of celite. The round bottom flask was further 
rinsed with EtOAc and was poured over the pad of celite. The filtrate was then washed with water. The 
aqueous phase was then extracted with EtOAc and the combined organic phases were washed 3 times 
with water. Organics were dried over anhydrous sodium sulfate, filtered over a cotton plug and solvent 
was removed under reduced pressure. The resulting compounds were purified by column 
chromatography, 20% EtOAc in hexanes or triturated using 50% EtOAc in hexanes. 
 
Synthesis of NW-2-081 (81a) 
 
NW-2-081 was prepared following the general procedure for double C-H functionalization (procedure 3) 
on a 0.42 mmol (0.2 g) scale. Yield: 64 % colourless solid. (m.p. 209-210 ᵒC) 1H NMR (CDCl3, 500 MHz) δ 
ppm 7.44-7.38 (m, 5H), 7.11 (d, J = 8.0 Hz, 2H), 6.94-6.86 (m, 2H), 6.77-6.69 (m, 4H), 4.82 (br s, 2H), 3.99 
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(s, 3H), 2.12 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 162.4, 143.2 (2C), 141.3 (2C), 137.6, 135.2 (2C), 
133.4 (2C), 130.4 (2C), 129.1, 129.0, 128.9, 128.7, 128.6, 128.2, 127.3 (2C), 126.8, 126.5, 125.0, 52.4, 
51.0, 21.2. (IR (NaCl): 3063, 2951, 2256, 1731, 1704, 1577, 1457, 1358, 1241, 1166, 1114, 1088. HRMS 
(EI): Exact mass calculated for C26H21NO4S2 [M + H]
+: 476.09848 found 476.09795. 
 
Synthesis of NW-2-074 (81c) 
 
NW-2-074 was prepared following the general procedure for double C-H functionalization (procedure 3) 
on a 0.42 mmol (0.2 g) scale. Yield: 99 % yellow solid. (m.p. 219-220 ᵒC) 1H NMR (CDCl3, 500 MHz) δ ppm 
7.33-7.29 (m, 1H), 7.10 (d, J = 8.5 Hz, 2H), 7.01-6.99 (m, 1H), 6.96-6.71 (m, 3H), 6.87-6.86 (m, 1H), 6.77-
6.73 (m, 4H), 4.82 (br s, 2H), 3.99 (s, 3H), 3.77 (s, 3H), 2.13 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 
162.4, 159.9, 143.2 (2C), 141.1, 137.6, 135.2 (2C), 134.6 (2C), 130.4, 130.1, 128.6 (2C), 128.2, 127.3, 
126.7, 126.4, 125.5, 125.1, 121.2, 114.9, 114.2, 55.3, 52.4, 51.0, 21.2. (IR (NaCl): 2951, 1731, 1703, 1597, 
1438, 1358, 1252, 1165, 1087, 1046. HRMS (EI): Exact mass calculated for C27H23NO5S2 [M + H]
+: 
506.10904 found 506.10909. 
 
Synthesis of NW-2-080 (81d) 
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NW-2-080 was prepared following the general procedure for double C-H functionalization (procedure 3) 
on a 0.42 mmol (0.2 g) scale. Yield: 90 % colourless solid. (m.p. 182-183 ᵒC) 1H NMR (CDCl3, 500 MHz) δ 
ppm 7.34 (d, J = 8.5 Hz, 2H), 7.10 (d, J = 8.5 Hz, 2H), 6.93-6.90 (m, 3H), 6.87-6.85 (m, 1H), 6.77-6.73 (m, 
4H), 4.81 (br s, 2H), 3.98 (s, 3H), 3.85 (s, 3H), 2.12 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 162.4, 160.3, 
143.2, 141.5 (2C), 137.6, 135.1, 130.3 (2C), 130.1 (2C), 128.8, 128.5, 127.7, 127.2, 127.1 (2C), 126.7, 
126.4, 125.5, 124.9, 124.8, 114.4, 55.3, 52.2, 50.9, 21.1. (IR (NaCl): 3003, 2951, 2839, 2256, 1730, 1703, 
1608, 1558, 1517, 1458, 1439, 1164, 1088, 1032, 911. HRMS (EI): Exact mass calculated for C27H23NO5S2 
[M + H]+: 506.10904 found 506.10893. 
 
Synthesis of NW-2-017 (81e) 
 
NW-2-017 was prepared following the general procedure for double C-H functionalization (procedure 3) 
on a 0.63 mmol (0.3 g) scale. Yield: 97 % clear oil. 1H NMR (CDCl3, 500 MHz) δ ppm 8.12-8.09 (m, 2H), 
7.58 (d, J = 8.0 Hz, 1H), 7.47 (t, J = 8.0 Hz, 1H), 7.11 (d, J = 8.0 Hz, 2H), 6.94-6.87 (m, 2H), 6.76-6.72 (m, 
3H), 6.62 (d, J = 8.0 Hz, 1H) 4.83 (br s, 2H), 4.38 (q, J = 7.5 Hz, 2H), 3.99 (s, 3H), 2.12 (s, 3H), 1.38 (t, J = 
7.5 Hz, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 165.8, 162.3, 143.3 (2C), 139.7 (2C), 137.7 (2C), 135.2, 
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133.8, 133.2, 131.5 (2C), 130.5, 130.1, 129.9, 129.1, 128.7 (2C), 127.5, 127.3, 126.9, 126.1, 124.8, 61.3, 
52.4, 51.0, 21.2, 14.3. (IR (NaCl): 2982, 2951, 1719, 1559, 1384, 1231, 1166, 1086, 1031. HRMS (EI): Exact 
mass calculated for C29H25NO6S2 [M + H]
+: 548.11961 found 548.12059. 
 
Synthesis of NW-2-153 (81f) 
 
NW-2-153 was prepared following the general procedure for double C-H functionalization (procedure 3) 
on a 0.62 mmol (0.3 g) scale. Yield: 81 % yellow solid (m.p. 110-111 ᵒC) 1H NMR (CDCl3, 500 MHz) δ ppm 
8.06 (d, J = 8.5 Hz, 2H), 7.50 (d, J = 8.5 Hz, 2H), 7.09 (d, J = 8.5 Hz, 2H), 6.95-6.86 (m, 2H), 6.76-6.65 (m, 
4H), 4.81 (br s, 2H), 4.40 (q, J = 7.5 Hz, 2H), 3.98 (s, 3H), 2.11 (s, 3H), 1.40 (t, J = 7.5 Hz, 3H). 13C NMR 
(CDCl3, 125 MHz) δ ppm 165.9, 162.2, 143.3 (2C), 139.6 (2C), 137.9, 137.8, 135.1, 130.9 (2C), 130.5, 
130.2, 128.9, 128.8, 128.6, 128.3, 127.6 (2C), 127.2, 126.8, 126.6, 126.3, 125.0, 61.2, 52.4, 50.9, 21.2, 
14.2. (IR (NaCl): 2951,1715, 1360, 1271, 1166, 1109, 1028. HRMS (EI): Exact mass calculated for 
C29H25NO6S2 [M + H]
+: 548.11961 found 548.11746. 
 
Synthesis of NW-2-083 (81g) 
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NW-2-083 was prepared following the general procedure for double C-H functionalization (procedure 3) 
on a 0.31 mmol (0.15 g) scale. Yield: 80 % yellow solid. (m.p. 171-172 ᵒC) 1H NMR (CDCl3, 500 MHz) δ 
ppm 7.31 (t, J = 8.0 Hz, 1H), 7.06-7.04 (m, 1H), 7.00-6.84 (m, 8H), 6.75-6.74 (m, 2H), 4.85 (br s, 2H), 3.99 
(s, 3H), 3.77 (s, 3H), 2.03 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 162.4, 159.9, 141.1, 138.3, 137.8, 
137.5, 134.6, 133.2, 130.1, 130.0, 128.5, 128.3, 127.8, 127.6, 127.4, 127.1, 126.3, 125.6, 125.0, 124.5, 
121.2, 114.9, 114.2, 55.3, 52.4, 51.1, 20.9. (IR (NaCl): 3446, 2951, 2837, 1732, 1703, 1598, 1487, 1462, 
1437, 1358, 1253, 1161, 1086, 1046, 959. HRMS (EI): Exact mass calculated for C27H23NO5S2 [M +H]
+: 
506.10904 found 506.11036. 
 
Synthesis of NW-2-098 (81h) 
 
NW-2-098 was prepared following the general procedure for double C-H functionalization (procedure 3) 
on a 0.42 mmol (0.2 g) scale. Yield: 81 % colourless solid. (m.p. 178-179 ᵒC) 1H NMR (CDCl3, 500 MHz) δ 
ppm 7.71 (d, J = 8.0 Hz, 1H), 7.32 (t, J = 7.5 Hz, 1H), 7.07-6.92 (m, 6H), 6.85 (t, J = 7.5 Hz, 1H), 6.79 (t, J = 
7.5 Hz, 1H), 6.73 (t, J = 8.0 Hz, 2H), 4.78 (s, 2H), 3.95 (s, 3H), 3.78 (s, 3H), 2.01 (s, 3H). 13C NMR (CDCl3, 
125 MHz) δ ppm 162.4, 159.9, 141.2, 137.9, 137.7, 137.6, 134.6 (2C), 132.5, 132.2, 130.5, 130.2, 128.6, 
128.4, 127.5, 127.2, 125.8, 125.6, 125.0, 124.6, 121.2, 114.9, 114.2, 55.3, 52.3, 50.5, 20.3. (IR (NaCl): 
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3061, 3002, 2951, 2837, 1731, 1703, 1597, 1578, 1462, 1439, 1354, 1254, 1166, 1047. HRMS (EI): Exact 
mass calculated for C27H23NO5S2 [M +H]
+: 506.10904 found 506.10876. 
 
Synthesis of NW-2-075 (81i) 
 
NW-2-075 was prepared following the general procedure for double C-H functionalization (procedure 3) 
on a 0.40 mmol (0.2 g) scale. Yield: 79 % yellow solid. (m.p. 219-220 ᵒC) 1H NMR (CDCl3, 500 MHz) δ ppm 
7.31 (td, Js = 1.5 Hz, Jl = 7.5 Hz, 1H), 7.15 (d, J = 9.0 Hz, 2H), 7.01-6.90 (m, 5H), 6.81-6.76 (m, 2H), 6.41 (d, 
J = 9.0 Hz, 2H), 4.83 (br s, 2H), 3.99 (s, 3H), 3.77 (s, 3H), 3.64 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 
162.6, 162.4, 159.9, 141.1, 137.7, 134.7 (2C), 130.4, 130.1, 129.8, 129.4, 128.6, 128.2, 127.5, 127.0, 
126.4 (2C), 125.5, 125.2, 121.2, 114.9, 114.2, 113.3, 55.4, 55.3, 52.4, 51.0. (IR (NaCl): 2949, 2841, 2362, 
1731, 1701, 1595, 1578, 1497, 1438, 1384, 1259, 1160, 1090, 1027, 781. HRMS (EI): Exact mass 
calculated for C27H23NO6S2 [M +H]
+: 522.10396 found 522.10364. 
 
Synthesis of NW-2-070 (81j) 
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NW-2-070 was prepared following the general procedure for double C-H functionalization (procedure 3) 
on a 0.62 mmol (0.3 g) scale. Yield: 78 % yellow solid. (m.p. 199-200 ᵒC) 1H NMR (CDCl3, 500 MHz) δ ppm 
7.31 (t, J = 7.5 Hz, 1H), 7.23-7.20 (m, 2H), 7.00-6.93 (m, 5H), 6.83-6.78 (m, 2H), 6.62 (t, J = 8.5 Hz, 2H), 
4.84 (br s, 2H), 3.98 (s, 3H), 3.76 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 165.8, 163.7, 162.2, 159.9, 
141.4, 137.1, 134.3, 134.1, 130.2, 130.0 (2C), 128.5, 128.1, 127.6, 127.2, 126.4, 125.7, 125.2, 121.1, 
115.2, 115.0 (2C), 114.1, 55.3, 52.4, 51.1. (IR (NaCl): 2951, 2362, 2337, 1731, 1302, 1590, 1491, 1361, 
1253, 1170, 1155, 1087. HRMS (EI): Exact mass calculated for C26H20BrFNO5S2 [M +H]
+: 510.08397 found 
510.08421. 
 
Synthesis of NW-3-043 (81b) 
 
NW-3-043 was prepared following the general procedure for double C-H functionalization (procedure 3) 
on a 0.21 mmol (0.1 g) scale. Yield: 96 % colourless solid. (m.p. 168-169 ᵒC) 1H NMR (CDCl3, 500 MHz) δ 
ppm 7.53 (s, 1H), 7.17-7.03 (m, 5H), 6.91 (d, J = 8.0 Hz, 1H), 6.76 (d, J = 8.0 Hz, 2H), 4.82 (br s, 2H), 3.96 
(s, 3H), 2.16 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 162.2, 143.4 (2C), 136.7, 134.9, 133.5 (2C), 129.1, 
128.7, 128.4, 127.8, 127.5, 127.4, 127.1, 126.2, 123.0, 120.9, 52.4, 50.6, 21.2. (IR (NaCl): 2951, 2256, 
1707, 1597, 1560, 1446, 1386, 1357, 1255, 1197, 1166. 
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General procedure for saponification (Procedure 4) 
 
A 1 : 2 : 1 mixture of 2 M NaOH(aq.) (5 equiv.), THF, MeOH (overall concentration 0.1 M) was added to the 
methyl ester (1 equiv.) and heated to reflux for 1 h. The mixture was cooled to 23 °C then diluted with 
EtOAc and brought to pH = 2 with 1 M HCl(aq.). The mixture was separated, and the aqueous phase was 
extracted with EtOAc. Combined organics were then washed three times with water, dried over 
anhydrous sodium sulfate and filtered over a plug of cotton. Solvent was removed under reduced 
pressure and used without further purification. 
 
General procedure for protodecarboxylation (Procedure 5) 
 
Conditions were based upon decarboxylative cross-coupling conditions established by Forgione and 
Bilodeau.35 The carboxylic acid (1 equiv.) in DMF (0.1 M) was added to a microwave vial containing 
PtBu3·HBF4 (0.05 equiv.), Cs2CO3 (1.5 equiv.) and PdCl2 (0.05 equiv.). The vial was then purged with argon 
and sealed with a microwave septum. The mixture was then irradiated in the microwave at 170 ᵒC for 8 
minutes. The resulting mixture was cooled to 23 °C then filtered over a packed pad of celite. The 
microwave vial was rinsed with EtOAc and was filtered over the celite. The filtrate was washed once 
with water and the aqueous phase was extracted with EtOAc. The organics were then combined and 
washed three times with water, dried over anhydrous sodium sulfate and filtered over a plug of cotton. 
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Solvent was then removed under reduced pressure. The compounds were purified by column 
chromatography using 20% EtOAc in hexanes as the eluent. 
 
Synthesis of NW-158 (4b) 
 
NW-158 was prepared following the general procedure for saponification (procedure 4) and the crude 
product was used in the general procedure for protodecarboxylation (procedure 5) on a 0.17 mmol (0.1 
g) scale. Yield: 55 % clear oil. 1H NMR (CDCl3, 500 MHz) δ ppm 7.51 (s, 1H), 7.44-7.41 (m, 2H), 7.38-7.35 
(m, 3H), 7.14-7.08 (m, 3H), 7.03-7.00 (m, 1H), 6.81-6.75 (m, 4H), 4.87 (s, 2H), 2.14 (s, 3H). 13C NMR 
(CDCl3, 125 MHz) δ ppm 143.1 (2C), 137.3(2C), 135.6 (2C), 134.9, 134.4, 130.3 (2C), 129.4, 129.0, 128.9, 
128.6, 128.4, 127.0 (3C), 126.7, 126.4, 125.0, 116.7, 51.2, 21.3. (IR (NaCl): 3122. 3062, 1597, 1578, 1555, 
1498, 1455, 1353, 1165, 1089, 1062, 912. HRMS (EI): Exact mass calculated for C24H19NO2S2 [M + H]
+: 
418.093 found 418.09153. 
 
Synthesis of NW-2-169 (4c) 
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NW-2-169 was prepared following the general procedure for saponification (procedure 4) and the crude 
product was used in the general procedure for protodecarboxylation (procedure 5) on a 0.17 mmol (0.1 
g) scale. Yield: 65 % yellow oil. 1H NMR (CDCl3, 500 MHz) δ ppm 7.49 (s, 1H), 7.29-7.26 (m, 1H), 7.13-7.07 
(m, 3H), 7.03-6.99 (m, 2H), 6.96-6.95 (m, 1H), 6.91-6.89 (m, 1H), 6.83-6.78 (m, 4H), 4.86 (s, 2H), 3.76 (s, 
3H), 2.14 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 159.8, 143.1 (2C), 137.2, 135.6, 135.5, 134.9, 130.2 
(2C), 129.9, 129.3, 128.6, 127.0 (2C), 126.9, 126.7, 126.3, 125.1, 121.4, 116.7, 114.3, 113.1, 55.3, 51.1, 
21.2. (IR (NaCl): 2922, 1598, 1578, 1494, 1353, 1164, 1090, 1048, 952. HRMS (EI): Exact mass calculated 
for C25H21NO3S2 [M + H]
+: 448.10356 found 448.10153. 
 
Synthesis of NW-136 (4d) 
 
NW-136 was prepared following the general procedure for saponification (procedure 4) and the crude 
product was used in the general procedure for protodecarboxylation (procedure 5) on a 0.21 mmol 
(0.12 g) scale. Yield: 78 % yellow oil. 1H NMR (CDCl3, 500 MHz) δ ppm 7.45 (s, 1H), 7.35-7.31 (m, 2H), 
7.12 (d, J = 8.5 Hz, 2H), 7.07 (d, J = 7.5 Hz, 1H), 7.03-6.99 (m, 1H), 6.91-6.88 (m, 2H), 6.81-6.77 (m, 4H), 
4.85 (s, 2H), 3.84 (s, 3H), 2.14 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 159.7, 143.0 (2C), 137.4 (2C), 
135.4 (2C), 134.9 (2C), 130.2 (2C), 129.5, 128.5, 127.0, 126.8, 126.6, 126.4, 126.2, 124.7 (2C), 116.0, 
114.3, 55.3, 51.1, 21.2. (IR (NaCl): 3123, 2935, 2837, 1608, 1513, 1351, 1291, 1249, 1164, 1034, 911. 
HRMS (EI): Exact mass calculated for C25H21NO3S2 [M + H]
+: 448.10356 found 448.10347. 
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Synthesis of NW-2-027 (4e) 
 
NW-2-027 was prepared following the general procedure for saponification (procedure 4) and the crude 
product was used in the general procedure for protodecarboxylation (procedure 5) on a 0.16 mmol (0.1 
g) scale. Yield: 84 % yellow oil. 1H NMR (CDCl3, 500 MHz) δ ppm 8.19 (s, 1H), 8.12-8.10 (m, 1H), 7.68-7.66 
(m, 1H), 7.57 (s, 1H), 7.49 (t, J = 8.0 Hz, 1H), 7.15-7.03 (m, 4H), 6.81-6.79 (m, 3H), 6.70-6.69 (m, 1H), 4.89 
(s, 2H), 2.15 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 170.4, 143.2 (2C), 135.8, 135.6, 135.1, 134.9, 
134.4, 130.6, 130.5, 130.0, 129.9, 129.2, 129.0, 128.7, 127.4, 127.3, 127.1, 127.0, 126.6, 124.7 (2C), 
117.4, 51.1, 21.3. (IR (NaCl): 2955, 2924, 2854, 1623, 1461, 1164, 1046. HRMS (EI): Exact mass calculated 
for C25H19NO4S2 [M + H]
+: 462.08283 found 462.08375. 
 
Synthesis of NW-2-033 (4f) 
 
NW-2-033 was prepared following the general procedure for saponification (procedure 4) and the crude 
product was used in the general procedure for protodecarboxylation (procedure 5) on a 0.16 mmol (0.1 
g) scale. Yield: 70 % yellow oil.1H NMR (CDCl3, 500 MHz) δ ppm 8.10 (d, J = 8.0 Hz, 2H), 7.59-7.56 (m, 3H), 
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7.14-7.06 (m, 4H), 6.84-6.75 (m, 4H), 4.88 (s, 2H), 2.15 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 170.7, 
143.2 (2C), 140.0, 136.1, 135.7 (2C), 134.9, 130.8 (2C), 130.6, 129.0, 128.9, 128.8, 128.7, 127.8, 127.5, 
127.1 (2C), 127.0, 126.6, 125.1, 117.9, 51.1, 21.3. (IR (NaCl): 2986, 1690, 1605, 1419, 1353, 1293, 1164, 
1089, 928. HRMS (EI): Exact mass calculated for C25H19NO4S2 [M + H]
+: 462.08283 found 462.08277. 
 
Synthesis of NW-2-007 (4g) 
 
NW-2-007 was prepared following the general procedure for saponification (procedure 4) and the crude 
product was used in the general procedure for protodecarboxylation (procedure 5) on a 0.17 mmol (0.1 
g) scale. Yield: 69 % yellow solid. (m.p. 114-115 ᵒC) 1H NMR (CDCl3, 500 MHz) δ ppm 7.51 (s, 1H), 7.28 (t, 
J = 8.5 Hz, 1H), 7.11-7.10 (m, 1H), 7.05-8.85 (m, 8H), 6.81-6.77 (m, 2H), 4.88 (s, 2H), 3.76 (s, 3H), 2.04 (s, 
3H). 13C NMR (CDCl3, 125 MHz) δ ppm 159.8, 138.2, 137.5, 137.2, 135.6, 135.5, 133.0, 130.0, 129.9, 
129.2, 127.7, 127.4, 127.0, 126.8, 126.3, 125.0 (2C), 124.2, 121.4, 117.1, 114.4, 114.1, 55.3, 51.2, 20.9. 
(IR (NaCl): 3122, 3065, 2937, 2835, 2256, 1599, 1576, 1464, 1353, 1224, 1224, 1047. HRMS (EI): Exact 
mass calculated for C25H21NO3S2 [M + H]
+: 448.10356 found 448.10361. 
 
Synthesis of NW-2-021 (4h) 
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NW-2-021 was prepared following the general procedure for saponification (procedure 4) and the crude 
product was used in the general procedure for protodecarboxylation (procedure 5) on a 0.17 mmol (0.1 
g) scale. Yield: 70 % yellow oil. 1H NMR (CDCl3, 500 MHz) δ ppm 7.69 (dd, Js = 1.0 Hz, Jl = 8.0 Hz, 1H), 
7.31-7.25 (m, 2H), 7.15 (td, Js = 1.5 Hz, Jl = 7.5 Hz, 1H), 7.05-6.97 (m, 6H), 6.93-6.85 (m, 3H), 4.87 (s, 2H), 
3.76 (s, 3H), 2.21 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 159.8, 137.4 (2C), 137.2, 135.4, 132.5, 132.3, 
130.8, 130.0, 129.9, 129.4, 127.3, 127.1, 126.6, 126.0, 125.7, 125.1 (2C), 121.5, 114.6, 114.2, 105.0, 55.3, 
50.3, 20.2. (IR (NaCl): 3063, 2937, 2836, 1605, 1578, 1555, 1494, 1464, 1349, 1224, 1164, 1065, 920. 
HRMS (EI): Exact mass calculated for C25H21NO3S2 [M + H]
+: 448.10356 found 448.10419. 
 
Synthesis of NW-156 (4i) 
 
NW-156 was prepared following the general procedure for saponification (procedure 4) and the crude 
product was used in the general procedure for protodecarboxylation (procedure 5) on a 0.20 mmol 
(0.12 g) scale. Yield: 68 % yellow oil. 1H NMR (CDCl3, 500 MHz) δ ppm 7.49 (s, 1H), 7.29-7.26 (m, 1H), 
7.16-7.13 (m, 2H), 7.11-7.09 (m, 1H), 7.05-6.99 (m, 2H), 6.96-6.89 (m, 2H), 6.85-6.79 (m, 2H), 6.46-6.43 
(m, 2H), 4.86 (s, 2H), 3.76 (s, 3H), 3.64 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 162.5, 159.8, 137.2 (2C), 
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135.6 (2C), 130.2 (2C), 129.9, 129.3, 129.1, 127.1 (2C), 126.8, 126.3, 125.1 (2C), 121.4, 116.8, 114.3, 
114.1, 113.2, 55.3 (2C), 51.1. (IR (NaCl): 3121, 2941, 2838, 1596, 1578, 1496, 1463, 1352, 1261, 1160, 
1091, 1049, 1028. HRMS (EI): Exact mass calculated for C25H21NO4S2 [M + H]
+: 464.09848 found 
464.09842. 
 
Synthesis of NW-2-103 (4j) 
 
NW-2-103 was prepared following the general procedure for saponification (procedure 4) and the crude 
product was used in the general procedure for protodecarboxylation (procedure 5) on a 0.17mmol (0.1 
g) scale. Yield: 78 % clear oil. 1H NMR (CDCl3, 500 MHz) δ ppm 7.53 (s, 1H), 7.29 (t, J = 7.5 Hz, 1H), 7.21-
7.19 (m, 2H), 7.11-6.94 (m, 5H), 6.86-6.81 (m, 2H), 6.64 (t, J = 8.5 Hz, 2H), 4.88 (s, 2H), 3.77 (s, 3H). 13C 
NMR (CDCl3, 125 MHz) δ ppm 159.8, 137.6 (2C), 135.4, 135.2, 130.0 (2C), 129.9, 129.7, 129.6, 129.2, 
127.4, 127.2, 126.7, 126.4, 125.2, 121.4, 117.5, 115.2, 115.0, 114.4, 114.2, 55.3, 51.3. (IR (NaCl): 2923, 
2851, 1589, 1492, 1356, 1224, 1168, 1156, 1047. HRMS (EI): Exact mass calculated for C24H18FNO3S2 [M + 
H]+: 452.07849 found 452.07859. 
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Procedure for decarboxylative cross-coupling (Procedure 6) (4a) 
 
Original conditions by Mitchell and co-workers were used with modifications.37 DMF (0.1 M) was added 
to a mixture of the carboxylic acid (0.102 mmol, 50 mg), PdCl2 (0.0051 mmol, 1 mg), dppf (0.0061 mmol, 
3.4 mg), Cs2CO3 (0.153 mmol, 50 mg) and 4-bromobenzonitrile (0.204 mmol, 37.2mg). The mixture was 
then heated to 100 °C for 3 h. The resulting mixture was cooled to room temperature, filtered over a 
packed pad of celite and the filtrate was washed once with water and the aqueous phase was extracted 
with EtOAc. The combined organics were then washed three times with water, dried over anhydrous 
sodium sulfate and filtered over a plug of cotton. Solvent was then removed under reduced pressure 
resulting in a yellow solid. Yield 62%. The solid was then purified by recrystalization with EtOAc and 
hexanes resulting in a yellow solid. Yield 22%. (m.p. 242-243 °C)  1H NMR (CDCl3, 500 MHz) δ ppm 8.01 
(d, J = 7.5 Hz, 2H), 7.72 (d, J = 7.5 Hz, 2H), 7,31 (t, J = 9.0 Hz, 1H), 7.06-6.94 (m, 7H), 6.77 (t, J = 7.5 Hz, 
1H), 6.71-6.68 (m, 3H), 4.93 (br s, 2H), 3.78 (s, 3H), 2.13 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 159.9, 
143.2 (2C), 138.2, 137.6, 134.9 (2C), 134.3, 134.2, 132.4 (2C), 132.2 (2C), 130.1, 130.0, 129.1 (2C), 128.4, 
128.3 (2C), 127.4, 127.3, 126.8, 126.6, 125.5, 121.3, 118.9, 114.4, 111.0, 55.4, 51.8, 21.3. (IR (NaCl): 
2921, 2226. 1603, 1578. 1490, 1355, 1287, 1184, 1165, 1089. 
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General procedure for saponification (Procedure 7) 
 
A 1:2:1 mixture of 2 M NaOH(aq.) (5 equiv.), THF, MeOH (overall concentration 0.1 M) was added to 
methyl ester (1 equiv.) and heated to reflux for 1 h. The mixture was diluted with EtOAc and brought to 
pH = 2 with 1 M HCl(aq.). The mixture was separated, and the aqueous phase was extracted with EtOAc. 
Combined organics were then washed three times with water, dried over sodium sulphate and filtered. 
Solvent was removed under reduced pressure and used without further purification. 
 
 
General procedure for decarboxylative cross-coupling (Procedure 8) 
 
Original conditions by Forgione and Bilodeau were used with modifications.54 The carboxylic acid (1 
equiv.) in DMF (0.1 M) was added to a flame dried round bottom flask containing PtBu3·HBF4 (0.05 
equiv.), Cs2CO3 (1.5 equiv.) and PdCl2 (0.05 equiv.).  The mixture was then heated to 170 ᵒC and stirred 
for 1 h. The resulting mixture was filtered over a hard pad of celite and the filtrate was washed once 
with water and the aqueous phase was extracted with EtOAc. The combined organics were then washed 
                                                          
54
 Forgione, P.; Brochu, M.-C.; St-Onge, M.; Thesen, K. H.; Bailey, M. D.; Bilodeau, F. J. Am. Chem. Soc. 2006, 128, 
11350 
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three times with water, dried over sodium sulphate and filtered. Solvent was then removed under 
reduced pressure. The resulting crude mixtures were purified by column chromatography using 20% 
EtOAc in hexanes as an eluent. 
 
Synthesis of NW-2-077 (6b) 
 
NW-2-077 was prepared following the general procedure for saponification (procedure 7) and the crude 
product was used in the general procedure for decarboxylative cross coupling (procedure 8) on a 0.43 
mmol (0.2 g) scale. Yield: 99 % yellow oil. 1H NMR (CDCl3, 500 MHz) δ ppm 7.37 (d, J = 5.5 Hz, 1H), 7.21 
(d, J = 5.5 Hz, 1H), 7.12-7.01 (m, 5H), 6.93-6.91 (m, 1H), 6.79-6.78 (m, 2H), 4.88 (s, 2H), 2.15 (s, 3H). 13C 
NMR (CDCl3, 125 MHz) δ ppm 143.3 (2C), 135.4, 134.0, 130.5 (2C), 128.5, 128.2, 127.9, 127.6, 127.4, 
127.0, 126.0, 125.8, 122.9, 122.1, 50.9, 21.2. (IR (NaCl): 2923, 2853, 1490, 1457, 1354, 1167, 1089, 1067, 
1028, 954, 768, 662, 582, 548. HRMS (EI): Exact mass calculated for C18H15NO2S2 [M + H]
+: 342.0617 
found 342.06038. 
 
Synthesis of NW-4-132 (6c) 
 
96 
 
NW-4-132 was prepared following the general procedure for saponification (procedure 7) and the crude 
product was used in the general procedure for decarboxylative cross coupling (procedure 8) on a 0.43 
mmol (0.2 g) scale. Yield: 98 % yellow oil. 1H NMR (CDCl3, 500 MHz) δ ppm 7.56 (d, J = 8.0 Hz, 1H), 7.29 
(d, J = 5.5 Hz, 1H), 7.17 (d, J = 5.5 Hz, 1H), 7.14-6.95 (m, 6H), 6.90-6.89 (d, J = 8.0 Hz, 1H), 4.88 (s, 2H), 
2.23 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 137.5, 136.7, 135.4, 132.6, 132.3, 129.7, 129.6, 128.4, 
128.3, 128.1, 127.5, 125.7, 125.5, 125.5, 123.0, 122.2, 50.4, 20.3,. (IR (NaCl): 3099, 2926, 2361, 1457, 
1351, 1167, 1065, 955, 600 
 
Synthesis of NW-4-133 (6d) 
 
NW-4-133 was prepared following the general procedure for saponification (procedure 7) and the crude 
product was used in the general procedure for decarboxylative cross coupling (procedure 8) on a 0.43 
mmol (0.2 g) scale. Yield: 97 % green oil. 1H NMR (CDCl3, 500 MHz) δ ppm 7.36 (d, J = 5.5 Hz, 1H), 7.21 (d, 
J = 5.5 Hz, 1H), 7.08-6.86 (m, 8H), 4.88 (s, 2H), 2.04 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 138.3, 
136.7, 135.4, 133.2, 130.7, 128.1, 127.9, 127.7, 127.7, 127.5, 127.4, 126.1, 125.8, 124.2, 122.9, 122.1, 
51.0, 20.9. (IR (NaCl): 3097, 2921, 1457, 1354, 1162, 1085, 1027, 954, 767, 601. 
 
Synthesis of NW-2-109 (6e) 
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NW-2-109 was prepared following the general procedure for saponification (procedure 7) and the crude 
product was used in the general procedure for decarboxylative cross coupling (procedure 8) on a 0.62 
mmol (0.3 g) scale. Yield: 99 % brown oil. 1H NMR (CDCl3, 500 MHz) δ ppm 7.36-7.34 (m, 1H), 7.21-7.19 
(m, 1H), 7.13-7.11 (m, 2H), 7.08-7.01 (m, 3H), 6.94-6.93 (m, 1H), 6.44 (d, J = 7.0 Hz, 2H), 4.86 (s, 2H), 3.64 
(s, 3H). 13C NMR (CDCl3, 125 MHz) δ ppm 162.7, 135.5 (2C), 130.5 (2C), 129.0, 128.4, 128.1, 127.8, 127.7, 
127.4, 126.0, 125.7, 122.8, 122.1, 113.1, 55.3, 50.8. (IR (NaCl): 3100, 2927, 2841, 1595, 1577, 1497, 
1355, 1258, 1166, 1091, 1025, 954, 833, 768, 664, 623, 554. HRMS (EI): Exact mass calculated for 
C18H15NO3S2 [M + H]
+: 358.05661 found 358.05548. 
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General procedure for bromination (Procedure 9) 
 
NBS (1 equiv.) was added to a mixture of thienoisoquinoline-phenylsulfonamide (1 equiv.) in a 1:1 
mixture of acetic acid to chloroform (0.2 M) at -5 ᵒC. The mixture was allowed to reach 23 ᵒC before 
subsequent heating to 60 ᵒC and allowed to stir for 16 h. The reaction mixture was cooled to 23 ᵒC and 
basified to pH = 9 with sodium bicarbonate. The resulting biphasic mixture was partitioned between 
EtOAc and water and extracted. The water phase was extracted with EtOAc and the combined organic 
phases were washed three times with water. The combined organics was then dried using sodium 
sulphate, filtered and solvent was removed under reduced pressure. Samples were purified by 
recrystalization using EtOAc and Hexanes. 
 
NW-2-150 (6a) 
 
NW-2-150 was prepared following the general procedure for bromination (procedure 9) on a 0.43 mmol 
(0.15 g) scale. Yield: 60 % colourless needles. 1H NMR (CDCl3, 500 MHz) δ ppm 7.37 (s, 1H), 7.15 (d, J = 
8.0 Hz, 2H), 7.09-6.99 (m, 3H), 6.84-6.79 (m, 3H), 4.84 (s, 2H), 2.17 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 
ppm 143.6 (2C), 134.9 (2C), 131.7 (2C), 128.7 (2C), 127.8, 127.7, 127.5, 127.5, 127.0, 125.9, 121.9, 110.7, 
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50.6, 21.2,. (IR (NaCl): 3107, 3049, 2894, 1597, 1532, 1459, 1356, 1166, 1089, 1034, 921, 812, 767, 664, 
583, 548. HRMS (EI): Exact mass calculated for C18H14BrNO2S2 [M + H]
+: 419.97221 found 419.9717. 
 
NW-2-125 (6f) 
 
NW-2-125 was prepared following the general procedure for bromination (procedure 9) on a 0.56 mmol 
(0.2 g) scale. Yield: 59 % colourless crystal. 1H NMR (CDCl3, 500 MHz) δ ppm 7.36 (s, 1H), 7.17 (d, J = 9.0 
Hz, 2H), 7.10-7.01 (m, 3H), 6.83-6.82 (d, J = 7.5 Hz, 1H), 6.48 (d, J = 9.0 Hz, 2H), 4.83 (s, 2H), 3.67 (s, 3H). 
13C NMR (CDCl3, 125 MHz) δ ppm 162.9, 135.1 (2C), 131.9 (2C), 129.1, 128.8, 128.0, 127.8 (2C), 127.5, 
125.9, 121.9 (2C), 113.3, 110.7, 55.4, 50.6. (IR (NaCl): 2943, 2840, 1595, 1496, 1355, 1261, 1160, 1030, 
832, 668, 585,555. HRMS (EI): Exact mass calculated for C18H14BrNO3S2 [M + H]
+: 435.96712 found 
435.96669. 
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CHAPTER 4 – CONCLUSION 
In summary, methods have been developed for the synthesis of two isomers of thienoisoquinolines.  
The syntheses employed the use of modern palladium cross-coupling reactions that are more 
environmentally friendly compared to their predecessors.  These reactions do not require preactivation 
in the form of organometallic reagents minimizing the quantity of metallic waste produced. 
Starting from a commercially available thiophene, the key intermediate of both isomers was obtained in 
2 steps. 
 
Scheme 47 – Synthesis of key intermediate 
Synthesis of the key intermediate began with commercially available 3-amino-2-methyl-
thiophenecarboxylate (1) and functionalized with a sulfonyl-chloride generating different sulfonamides 
(78).  Sulfonamides were benzylated using bromobenzylbromide, generating the key intermediate (2).  
This two step synthesis was conducted on multigram scale using only recrystalization as a purification 
method.  Recrystalization is a green purification alternative to silica gel chromatography using less 
solvent and without the requirement of silica gel. 
The key intermediate (2) was subjected to two different sequences of reactions giving different isomers, 
which lead to a variety of functionalized thienoisoquinolines. 
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Scheme 48 – Summary of the syntheses of functionalized thienoisoquinolines 
Subjecting the key intermediate to palladium catalysis conditions with a second aryl bromide facilitates a 
double C-H activation reaction.  An intramolecular C-H activation occurs forming a carbon-carbon bond 
at generally less reactive C4 position due to an ester functionality at C2 acting as a blocking group.  The 
second C-H activation can occur at the C5 position of the 3,4-thienoisoquinoline functionalizing with a 
variety of aromatic substituents.  The overall process occurred in good to excellent yields for a variety of 
electronically and sterically different substituents.  The ester could be saponified revealing the 
carboxylic acid giving a synthetic handle for further transformations.  The acid can be 
protodecarboxylated to functionalize the C2 position with a hydrogen that was found to occur readily 
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with a variety of Ar and Ar2 substituents.  The acid could also be subjected under palladium catalysis 
conditions to undergo a decarboxylative cross-coupling to substitute the C2 position with different aryl 
substituents.  Although the resulting yield was low, further optimization studies are required to increase 
yield of the transformation. 
Altering the order of reactions performed on the key intermediate allowed for the synthesis of 
functionalized 2,3-thienoisoquinolines (7).  The carboxylic acid was unmasked through a saponification 
of the corresponding ester.  Decarboxylative cross-coupling was then performed on the acid to form 
unfunctionalized 2,3-thienoisoquinolines.  These intermediates (6) were brominated with NBS resulting 
in functionalization with a bromine at C5.  Furthermore, the intermediates (6), were also functionalized 
at C5 with a variety of aryl functionalities using C-H activation.  The synthesis was further improved by 
combining both decarboxylative cross-coupling and functionalization through C-H activation into a single 
set of conditions.  For the one-pot transformation, a palladium/ligand combination, base, reaction 
temperature and time were optimized.  Future work involves the determination of the substrate scope 
of the transformation. 
Presented are two complimentary routes to access different functionalized thienoisoquinoline systems, 
which have been shown to be biologically active against breast cancer.  The syntheses of both isomers 
employ modern alternatives to classical cross-coupling reactions, C-H activation and decarboxylative 
cross-coupling.  This modular system allows for the generation a library of these important compounds 
while minimizing environmental impact 
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